Publications

Publications published since 2005 from OUS - Section for Preventive Cardiology

304 publications found

Publications 2023

1. Sanders AM, Richard G, Kolskår K, Ulrichsen KM, Alnaes D, Beck D, Dørum ES, Engvig A, Lund MJ, Nordhøy W, Pedersen ML, Rokicki J, Nordvik JE, Westlye LT (2023)
   Associations between everyday activities and arterial spin labeling-derived cerebral blood flow: A longitudinal study in community-dwelling elderly volunteers
   Hum Brain Mapp (in press)
   DOI 10.1002/hbm.26287, PubMed 36947581
2. Svilaas T, Klemsdal TO, Bogsrud MP, Græsdal A, Vesterbekkmo EK, Asprusten EA, Langslet G, Retterstøl K (2023)
   [Not Available]
   Tidsskr Nor Laegeforen, 143 (2)
   DOI 10.4045/tidsskr.23.0023, PubMed 36718898
3. Ødegård RA, Júlíusson PB, Kokkvoll AS, Kristiansen H, Köpp UMS, Rolin J, Shah S, Svendsen M, Hjelmesæth J (2023)
   [Not Available]
   Tidsskr Nor Laegeforen, 143 (3)
   DOI 10.4045/tidsskr.23.0069, PubMed 36811423

Publications 2022

1. Atar D, Langslet G, Tonstad S (2022)
   Do we need new lipid-lowering agents in the era of PCSK9 inhibitors? Recent advances
   Kardiol Pol, 80 (7-8), 741-749
   DOI 10.33963/KP.a2022.0117, PubMed 35521719
2. Bergum H, Sandven I, Abdelnoor M, Anderssen SA, Grimsmo J, Rivrud DE, Myhr NE, Vold MB, Stenbakken C, Lidfors B, Dufseth L, Klemsdal TO (2022)
   Randomized trial of cardiovascular prevention in Norway combining an in-hospital lifestyle course with primary care follow-up: the Hjerteløftet study
   Eur J Prev Cardiol, 29 (17), 2252-2263
   DOI 10.1093/eurjpc/zwac211, PubMed 36124709
3. Driva S, Korkontzelou A, Tonstad S, Tentolouris N, Katsaounou P (2022)
   The Effect of Smoking Cessation on Body Weight and Other Metabolic Parameters with Focus on People with Type 2 Diabetes Mellitus
   Int J Environ Res Public Health, 19 (20)
   DOI 10.3390/ijerph192013222, PubMed 36293800
4. Dybvik JS, Svendsen M, Aune D (2022)
   Vegetarian and vegan diets and the risk of cardiovascular disease, ischemic heart disease and stroke: a systematic review and meta-analysis of prospective cohort studies
   Eur J Nutr, 62 (1), 51-69
   DOI 10.1007/s00394-022-02942-8, PubMed 36030329
5. Heggen E, Omland T, Tonstad S (2022)
   Effect of smoking cessation on cardiac troponin I concentrations
   Scand J Clin Lab Invest, 82 (2), 104-107
   DOI 10.1080/00365513.2022.2031277, PubMed 35112632
6. Le Foll B, Piper ME, Fowler CD, Tonstad S, Bierut L, Lu L, Jha P, Hall WD (2022)
   Tobacco and nicotine use
   Nat Rev Dis Primers, 8 (1), 19
   DOI 10.1038/s41572-022-00346-w, PubMed 35332148
7. Meyer HE, Selmer R, Rabanal KS, Klemsdal TO (2022)
   Many refugees are at a high risk of cardiovascular disease
   Tidsskr Nor Laegeforen, 142 (12)
   DOI 10.4045/tidsskr.22.0365, PubMed 36066236
8. Munkhaugen J, Kristiansen O, Sverre E, Retterstøl K, Tonstad S (2022)
   Statins seldom cause adverse reactions
   Tidsskr Nor Laegeforen, 142 (2)
   DOI 10.4045/tidsskr.21.0885, PubMed 35107944
9. Ringen PA, Lund-Stenvold E, Andreassen OA, Gaarden TL, Hartberg CB, Johnsen E, Myklatun S, Osnes K, Sørensen K, Sørensen K, Vaaler A, Tonstad S, Engh JA, Høye A (2022)
   Quality of clinical management of cardiometabolic risk factors in patients with severe mental illness in a specialist mental health care setting
   Nord J Psychiatry, 76 (8), 602-609
   DOI 10.1080/08039488.2022.2039288, PubMed 35200088
10. Svilaas T, Klemsdal TO, Bogsrud MP, Græsdal A, Vesterbekkmo EK, Asprusten EA, Langslet G, Retterstøl K (2022)
    High levels of lipoprotein(a) - assessment and treatment
    Tidsskr Nor Laegeforen, 142 (1)
    DOI 10.4045/tidsskr.21.0800, PubMed 36655975
11. Tønnesen P, Lawrence D, Tonstad S (2022)
    Medication-assisted quit rates in participants with smoking-related diseases in EAGLES: Post hoc analyses of a double-blind, randomized, placebo-controlled clinical trial
    Tob Induc Dis, 20, 46
    DOI 10.18332/tid/146567, PubMed 35611069
12. Visseren FLJ, Mach F, Smulders YM, Carballo D, Koskinas KC, Bäck M, Benetos A, Biffi A, Boavida JM, Capodanno D, Cosyns B, Crawford C, Davos CH, Desormais I, Angelantonio ED, Franco OH, Halvorsen S, Richard Hobbs FD, Hollander M, Jankowska EA, Michal M, Sacco S, Sattar N, Tokgozoglu L, Tonstad S et al. (2022)
    2021 ESC Guidelines on cardiovascular disease prevention in clinical practice: Developed by the Task Force for cardiovascular disease prevention in clinical practice with representatives of the European Society of Cardiology and 12 medical societies With the special contribution of the European Association of Preventive Cardiology (EAPC)
    Rev Esp Cardiol (Engl Ed), 75 (5), 429
    DOI 10.1016/j.rec.2022.04.003, PubMed 35525570
13. Visseren FLJ, Mach F, Smulders YM, Carballo D, Koskinas KC, Bäck M, Benetos A, Biffi A, Boavida JM, Capodanno D, Cosyns B, Crawford C, Davos CH, Desormais I, Di Angelantonio E, Franco OH, Halvorsen S, Hobbs FDR, Hollander M, Jankowska EA, Michal M, Sacco S, Sattar N, Tokgozoglu L, Tonstad S et al. (2022)
    2021 ESC Guidelines on cardiovascular disease prevention in clinical practice
    Eur J Prev Cardiol, 29 (1), 5-115
    DOI 10.1093/eurjpc/zwab154, PubMed 34558602
14. Visseren FLJ, Mach F, Smulders YM, Carballo D, Koskinas KC, Bäck M, Benetos A, Biffi A, Boavida JM, Capodanno D, Cosyns B, Crawford C, Davos CH, Desormais I, Di Angelantonio E, Franco OH, Halvorsen S, Hobbs FDR, Hollander M, Jankowska EA, Michal M, Sacco S, Sattar N, Tokgozoglu L, Tonstad S et al. (2022)
    [2021 ESC Guidelines on cardiovascular disease prevention in clinical practice]
    G Ital Cardiol (Rome), 23 (6 Suppl 1), e3-e115
    DOI 10.1714/3808.37926, PubMed 35708476

Publications 2021

1. Bergum H, Sandven I, Klemsdal TO (2021)
   Long-term effects (> 24 months) of multiple lifestyle intervention on major cardiovascular risk factors among high-risk subjects: a meta-analysis
   BMC Cardiovasc Disord, 21 (1), 181
   DOI 10.1186/s12872-021-01989-5, PubMed 33858345
2. Deedwania P, Murphy SA, Scheen A, Badariene J, Pineda AL, Honarpour N, Keech AC, Sever PS, Pedersen TR, Sabatine MS, Giugliano RP (2021)
   Efficacy and Safety of PCSK9 Inhibition With Evolocumab in Reducing Cardiovascular Events in Patients With Metabolic Syndrome Receiving Statin Therapy: Secondary Analysis From the FOURIER Randomized Clinical Trial
   JAMA Cardiol, 6 (2), 139-147
   DOI 10.1001/jamacardio.2020.3151, PubMed 32785614
3. Fredwall SO, Linge J, Leinhard OD, Kjønigsen L, Eggesbø HB, Weedon-Fekjær H, Lidal IB, Månum G, Savarirayan R, Tonstad S (2021)
   Correction to: Cardiovascular risk factors and body composition in adults with achondroplasia
   Genet Med, 23 (11), 2234
   DOI 10.1038/s41436-021-01201-1, PubMed 34234305
4. Keech AC, Oyama K, Sever PS, Tang M, Murphy SA, Hirayama A, Lu C, Tay L, Deedwania PC, Siu CW, Lira Pineda A, Choi D, Charng MJ, Amerena J, Wan Ahmad WA, Chopra VK, Pedersen TR, Giugliano RP, Sabatine MS, FOURIER Study Group (2021)
   Efficacy and Safety of Long-Term Evolocumab Use Among Asian Subjects　- A Subgroup Analysis of the Further Cardiovascular Outcomes Research With PCSK9 Inhibition in Subjects With Elevated Risk (FOURIER) Trial
   Circ J, 85 (11), 2063-2070
   DOI 10.1253/circj.CJ-20-1051, PubMed 33980763
5. Scholz JR, Abe TO, Gaya PV, Bellini B, de Moraes IRA, Santos JR, Tomaz PRX, de Lima Santos PC, Tonstad S (2021)
   Cue restricted smoking increases quit rates with varenicline
   Tob Prev Cessat, 7, 33
   DOI 10.18332/tpc/133570, PubMed 34017927
6. Vallejo-Vaz AJ, Packard CJ, Ference BA, Santos RD, Kastelein JJP, Stein EA, Catapano AL, Pedersen TR, Watts GF, Ray KK (2021)
   LDL-cholesterol lowering and clinical outcomes in hypercholesterolemic subjects with and without a familial hypercholesterolemia phenotype: Analysis from the secondary prevention 4S trial
   Atherosclerosis, 320, 1-9
   DOI 10.1016/j.atherosclerosis.2021.01.003, PubMed 33497862
7. Visseren FLJ, Mach F, Smulders YM, Carballo D, Koskinas KC, Bäck M, Benetos A, Biffi A, Boavida JM, Capodanno D, Cosyns B, Crawford C, Davos CH, Desormais I, Di Angelantonio E, Franco OH, Halvorsen S, Hobbs FDR, Hollander M, Jankowska EA, Michal M, Sacco S, Sattar N, Tokgozoglu L, Tonstad S et al. (2021)
   2021 ESC Guidelines on cardiovascular disease prevention in clinical practice
   Eur Heart J, 42 (34), 3227-3337
   DOI 10.1093/eurheartj/ehab484, PubMed 34458905

Publications 2020

1. Bergmark BA, O'Donoghue ML, Murphy SA, Kuder JF, Ezhov MV, Ceška R, Gouni-Berthold I, Jensen HK, Tokgozoglu SL, Mach F, Huber K, Gaciong Z, Lewis BS, Schiele F, Jukema JW, Pedersen TR, Giugliano RP, Sabatine MS (2020)
   An Exploratory Analysis of Proprotein Convertase Subtilisin/Kexin Type 9 Inhibition and Aortic Stenosis in the FOURIER Trial
   JAMA Cardiol, 5 (6), 709-713
   DOI 10.1001/jamacardio.2020.0728, PubMed 32347887
2. Fredwall SO, Linge J, Leinhard OD, Kjønigsen L, Eggesbø HB, Weedon-Fekjær H, Lidal IB, Månum G, Savarirayan R, Tonstad S (2020)
   Cardiovascular risk factors and body composition in adults with achondroplasia
   Genet Med, 23 (4), 732-739
   DOI 10.1038/s41436-020-01024-6, PubMed 33204020
3. Gencer B, Mach F, Guo J, Im K, Ruzza A, Wang H, Kurtz CE, Pedersen TR, Keech AC, Ott BR, Sabatine MS, Giugliano RP, FOURIER Investigators (2020)
   Cognition After Lowering LDL-Cholesterol With Evolocumab
   J Am Coll Cardiol, 75 (18), 2283-2293
   DOI 10.1016/j.jacc.2020.03.039, PubMed 32381158
4. Gencer B, Mach F, Murphy SA, De Ferrari GM, Huber K, Lewis BS, Ferreira J, Kurtz CE, Wang H, Honarpour N, Keech AC, Sever PS, Pedersen TR, Sabatine MS, Giugliano RP (2020)
   Efficacy of Evolocumab on Cardiovascular Outcomes in Patients With Recent Myocardial Infarction: A Prespecified Secondary Analysis From the FOURIER Trial
   JAMA Cardiol, 5 (8), 952-957
   DOI 10.1001/jamacardio.2020.0882, PubMed 32432684
5. Johansen N, Tonstad S, Liavaag AH, Selmer RM, Tanbo TG, Michelsen TM (2020)
   Risk of cardiovascular disease after preventive salpingo-oophorectomy
   Int J Gynecol Cancer, 30 (5), 575-582
   DOI 10.1136/ijgc-2019-000856, PubMed 32332121
6. Landmesser U, Pirillo A, Farnier M, Jukema JW, Laufs U, Mach F, Masana L, Pedersen TR, Schiele F, Steg G, Tubaro M, Zaman A, Zamorano P, Catapano AL (2020)
   Lipid-lowering therapy and low-density lipoprotein cholesterol goal achievement in patients with acute coronary syndromes: The ACS patient pathway project
   Atheroscler Suppl, 42, e49-e58
   DOI 10.1016/j.atherosclerosissup.2021.01.009, PubMed 33589224
7. Mach F, Baigent C, Catapano AL, Koskinas KC, Casula M, Badimon L, Chapman MJ, De Backer GG, Delgado V, Ference BA, Graham IM, Halliday A, Landmesser U, Mihaylova B, Pedersen TR, Riccardi G, Richter DJ, Sabatine MS, Taskinen MR, Tokgozoglu L, Wiklund O, ESC Scientific Document Group (2020)
   2019 ESC/EAS Guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk
   Eur Heart J, 41 (1), 111-188
   DOI 10.1093/eurheartj/ehz455, PubMed 31504418
8. Marston NA, Gurmu Y, Melloni GEM, Bonaca M, Gencer B, Sever PS, Pedersen TR, Keech AC, Roselli C, Lubitz SA, Ellinor PT, O'Donoghue ML, Giugliano RP, Ruff CT, Sabatine MS (2020)
   The Effect of PCSK9 (Proprotein Convertase Subtilisin/Kexin Type 9) Inhibition on the Risk of Venous Thromboembolism
   Circulation, 141 (20), 1600-1607
   DOI 10.1161/CIRCULATIONAHA.120.046397, PubMed 32223429
9. Rabanal KS, Igland J, Tell GS, Jenum AK, Klemsdal TO, Ariansen I, Meyer HE, Selmer RM (2020)
   Validation of the cardiovascular risk model NORRISK 2 in South Asians and people with diabetes
   Scand Cardiovasc J, 55 (1), 56-62
   DOI 10.1080/14017431.2020.1821909, PubMed 33073627
10. Svendsen M (2020)
    PLANT-BASED DIET: why you should eat greener, and how to do it in practice
    Tidsskr. Nor. Laegeforen., 140 (2), 181
11. Tonstad S, Arons C, Rollema H, Berlin I, Hajek P, Fagerström K, Els C, McRae T, Russ C (2020)
    Varenicline: mode of action, efficacy, safety and accumulated experience salient for clinical populations
    Curr Med Res Opin, 36 (5), 713-730
    DOI 10.1080/03007995.2020.1729708, PubMed 32050807
12. Tonstad S, Klemsdal TO, Dusanov S, Gulseth H (2020)
    Randomized trials of diet and persistent organic pollutants: Reply to Drs. Lee and Lee
    Nutr Metab Cardiovasc Dis, 30 (5), 851-852
    DOI 10.1016/j.numecd.2020.02.019, PubMed 32276864
13. Wiviott SD, Giugliano RP, Morrow DA, De Ferrari GM, Lewis BS, Huber K, Kuder JF, Murphy SA, Forni DM, Kurtz CE, Honarpour N, Keech AC, Sever PS, Pedersen TR, Sabatine MS (2020)
    Effect of Evolocumab on Type and Size of Subsequent Myocardial Infarction: A Prespecified Analysis of the FOURIER Randomized Clinical Trial
    JAMA Cardiol, 5 (7), 787-793
    DOI 10.1001/jamacardio.2020.0764, PubMed 32347885

Publications 2019

1. Berlin I, Tonstad S (2019)
   It's Time to Bury the "Smoker's Paradox"
   Nicotine Tob Res, 21 (9), 1149-1150
   DOI 10.1093/ntr/ntz106, PubMed 31231769
2. Charytan DM, Sabatine MS, Pedersen TR, Im K, Park JG, Pineda AL, Wasserman SM, Deedwania P, Olsson AG, Sever PS, Keech AC, Giugliano RP, FOURIER Steering Committee and Investigators (2019)
   Efficacy and Safety of Evolocumab in Chronic Kidney Disease in the FOURIER Trial
   J Am Coll Cardiol, 73 (23), 2961-2970
   DOI 10.1016/j.jacc.2019.03.513, PubMed 31196453
3. Greve AM, Bang CN, Boman K, Egstrup K, Kesäniemi YA, Ray S, Pedersen TR, Wachtell K (2019)
   Relation of Lipid-Lowering Therapy to Need for Aortic Valve Replacement in Patients With Asymptomatic Mild to Moderate Aortic Stenosis
   Am J Cardiol, 124 (11), 1736-1740
   DOI 10.1016/j.amjcard.2019.08.037, PubMed 31586530
4. Marston NA, Kamanu FK, Nordio F, Gurmu Y, Roselli C, Sever PS, Pedersen TR, Keech AC, Wang H, Lira Pineda A, Giugliano RP, Lubitz SA, Ellinor PT, Sabatine MS, Ruff CT (2019)
   Predicting Benefit From Evolocumab Therapy in Patients With Atherosclerotic Disease Using a Genetic Risk Score: Results From the FOURIER Trial
   Circulation, 141 (8), 616-623
   DOI 10.1161/CIRCULATIONAHA.119.043805, PubMed 31707849
5. Murphy SA, Pedersen TR, Gaciong ZA, Ceska R, Ezhov MV, Connolly DL, Jukema JW, Toth K, Tikkanen MJ, Im K, Wiviott SD, Kurtz CE, Honarpour N, Giugliano RP, Keech AC, Sever PS, Sabatine MS (2019)
   Effect of the PCSK9 Inhibitor Evolocumab on Total Cardiovascular Events in Patients With Cardiovascular Disease: A Prespecified Analysis From the FOURIER Trial
   JAMA Cardiol, 4 (7), 613-619
   DOI 10.1001/jamacardio.2019.0886, PubMed 31116355
6. O'Donoghue ML, Fazio S, Giugliano RP, Stroes ESG, Kanevsky E, Gouni-Berthold I, Im K, Lira Pineda A, Wasserman SM, Češka R, Ezhov MV, Jukema JW, Jensen HK, Tokgözoğlu SL, Mach F, Huber K, Sever PS, Keech AC, Pedersen TR, Sabatine MS (2019)
   Lipoprotein(a), PCSK9 Inhibition, and Cardiovascular Risk
   Circulation, 139 (12), 1483-1492
   DOI 10.1161/CIRCULATIONAHA.118.037184, PubMed 30586750
7. Qamar A, Giugliano RP, Keech AC, Kuder JF, Murphy SA, Kurtz CE, Wasserman SM, Sever PS, Pedersen TR, Sabatine MS (2019)
   Interindividual Variation in Low-Density Lipoprotein Cholesterol Level Reduction With Evolocumab: An Analysis of FOURIER Trial Data
   JAMA Cardiol, 4 (1), 59-63
   DOI 10.1001/jamacardio.2018.4178, PubMed 30540337

Publications 2018

1. Aune D, Keum N, Giovannucci E, Fadnes LT, Boffetta P, Greenwood DC, Tonstad S, Vatten LJ, Riboli E, Norat T (2018)
   Dietary intake and blood concentrations of antioxidants and the risk of cardiovascular disease, total cancer, and all-cause mortality: a systematic review and dose-response meta-analysis of prospective studies
   Am J Clin Nutr, 108 (5), 1069-1091
   DOI 10.1093/ajcn/nqy097, PubMed 30475962
2. Benowitz NL, Pipe A, West R, Hays JT, Tonstad S, McRae T, Lawrence D, St Aubin L, Anthenelli RM (2018)
   Cardiovascular Safety of Varenicline, Bupropion, and Nicotine Patch in Smokers: A Randomized Clinical Trial
   JAMA Intern Med, 178 (5), 622-631
   DOI 10.1001/jamainternmed.2018.0397, PubMed 29630702
3. Bohula EA, Giugliano RP, Leiter LA, Verma S, Park JG, Sever PS, Lira Pineda A, Honarpour N, Wang H, Murphy SA, Keech A, Pedersen TR, Sabatine MS (2018)
   Inflammatory and Cholesterol Risk in the FOURIER Trial
   Circulation, 138 (2), 131-140
   DOI 10.1161/CIRCULATIONAHA.118.034032, PubMed 29530884
4. Botteri E, de Lange T, Tonstad S, Berstad P (2018)
   Exploring the effect of a lifestyle intervention on cancer risk: 43-year follow-up of the randomized Oslo diet and antismoking study
   J Intern Med, 284 (3), 282-291
   DOI 10.1111/joim.12765, PubMed 29790221
5. Giugliano RP, Keech AC, Sever PS, Pedersen TR, Sabatine MS (2018)
   Clinical benefits of evolocumab appear less than hoped - Authors' reply
   Lancet, 391 (10124), 934-935
   DOI 10.1016/S0140-6736(18)30529-4, PubMed 29536853
6. Jortveit J, Kaldal A, Tonstad S (2018)
   Prevalence of diabetes before and after first diagnosis of coronary artery disease
   Tidsskr Nor Laegeforen, 138 (5)
   DOI 10.4045/tidsskr.17.0539, PubMed 29513466
7. Martin SS, Giugliano RP, Murphy SA, Wasserman SM, Stein EA, Ceška R, López-Miranda J, Georgiev B, Lorenzatti AJ, Tikkanen MJ, Sever PS, Keech AC, Pedersen TR, Sabatine MS (2018)
   Comparison of Low-Density Lipoprotein Cholesterol Assessment by Martin/Hopkins Estimation, Friedewald Estimation, and Preparative Ultracentrifugation: Insights From the FOURIER Trial
   JAMA Cardiol, 3 (8), 749-753
   DOI 10.1001/jamacardio.2018.1533, PubMed 29898218
8. Nicholls SJ, Lincoff AM, Bash D, Ballantyne CM, Barter PJ, Davidson MH, Kastelein JJP, Koenig W, McGuire DK, Mozaffarian D, Pedersen TR, Ridker PM, Ray K, Karlson BW, Lundström T, Wolski K, Nissen SE (2018)
   Assessment of omega-3 carboxylic acids in statin-treated patients with high levels of triglycerides and low levels of high-density lipoprotein cholesterol: Rationale and design of the STRENGTH trial
   Clin Cardiol, 41 (10), 1281-1288
   DOI 10.1002/clc.23055, PubMed 30125052
9. Sabatine MS, De Ferrari GM, Giugliano RP, Huber K, Lewis BS, Ferreira J, Kuder JF, Murphy SA, Wiviott SD, Kurtz CE, Honarpour N, Keech AC, Sever PS, Pedersen TR (2018)
   Clinical Benefit of Evolocumab by Severity and Extent of Coronary Artery Disease: Analysis From FOURIER
   Circulation, 138 (8), 756-766
   DOI 10.1161/CIRCULATIONAHA.118.034309, PubMed 29626068
10. Thorolfsdottir RB, Sveinbjornsson G, Sulem P, Nielsen JB, Jonsson S, Halldorsson GH, Melsted P, Ivarsdottir EV, Davidsson OB, Kristjansson RP, Thorleifsson G, Helgadottir A, Gretarsdottir S, Norddahl G, Rajamani S, Torfason B, Valgardsson AS, Sverrisson JT, Tragante V, Holmen OL, Asselbergs FW, Roden DM, Darbar D, Pedersen TR, Sabatine MS et al. (2018)
    Coding variants in RPL3L and MYZAP increase risk of atrial fibrillation
    Commun Biol, 1, 68
    DOI 10.1038/s42003-018-0068-9, PubMed 30271950
11. Willeit P, Ridker PM, Nestel PJ, Simes J, Tonkin AM, Pedersen TR, Schwartz GG, Olsson AG, Colhoun HM, Kronenberg F, Drechsler C, Wanner C, Mora S, Lesogor A, Tsimikas S (2018)
    Baseline and on-statin treatment lipoprotein(a) levels for prediction of cardiovascular events: individual patient-data meta-analysis of statin outcome trials
    Lancet, 392 (10155), 1311-1320
    DOI 10.1016/S0140-6736(18)31652-0, PubMed 30293769

Publications 2017

1. Aune D, Giovannucci E, Boffetta P, Fadnes LT, Keum N, Norat T, Greenwood DC, Riboli E, Vatten LJ, Tonstad S (2017)
   Fruit and vegetable intake and the risk of cardiovascular disease, total cancer and all-cause mortality-a systematic review and dose-response meta-analysis of prospective studies
   Int J Epidemiol, 46 (3), 1029-1056
   DOI 10.1093/ije/dyw319, PubMed 28338764
2. Aune D, Schlesinger S, Henriksen T, Saugstad OD, Tonstad S (2017)
   Physical activity and the risk of preterm birth: a systematic review and meta-analysis of epidemiological studies
   BJOG, 124 (12), 1816-1826
   DOI 10.1111/1471-0528.14672, PubMed 28374930
3. Aune D, Sen A, Leitzmann MF, Norat T, Tonstad S, Vatten LJ (2017)
   Body mass index and physical activity and the risk of diverticular disease: a systematic review and meta-analysis of prospective studies
   Eur J Nutr, 56 (8), 2423-2438
   DOI 10.1007/s00394-017-1443-x, PubMed 28393286
4. Aune D, Sen A, ó'Hartaigh B, Janszky I, Romundstad PR, Tonstad S, Vatten LJ (2017)
   Resting heart rate and the risk of cardiovascular disease, total cancer, and all-cause mortality - A systematic review and dose-response meta-analysis of prospective studies
   Nutr Metab Cardiovasc Dis, 27 (6), 504-517
   DOI 10.1016/j.numecd.2017.04.004, PubMed 28552551
5. Aune D, Sen A, Schlesinger S, Norat T, Janszky I, Romundstad P, Tonstad S, Riboli E, Vatten LJ (2017)
   Body mass index, abdominal fatness, fat mass and the risk of atrial fibrillation: a systematic review and dose-response meta-analysis of prospective studies
   Eur J Epidemiol, 32 (3), 181-192
   DOI 10.1007/s10654-017-0232-4, PubMed 28194602
6. Bonaca MP, Nault P, Giugliano RP, Keech AC, Pineda AL, Kanevsky E, Kuder J, Murphy SA, Jukema JW, Lewis BS, Tokgozoglu L, Somaratne R, Sever PS, Pedersen TR, Sabatine MS (2017)
   Low-Density Lipoprotein Cholesterol Lowering With Evolocumab and Outcomes in Patients With Peripheral Artery Disease: Insights From the FOURIER Trial (Further Cardiovascular Outcomes Research With PCSK9 Inhibition in Subjects With Elevated Risk)
   Circulation, 137 (4), 338-350
   DOI 10.1161/CIRCULATIONAHA.117.032235, PubMed 29133605
7. Catapano AL, Graham I, De Backer G, Wiklund O, Chapman MJ, Drexel H, Hoes AW, Jennings CS, Landmesser U, Pedersen TR, Reiner Ž, Riccardi G, Taskinen MR, Tokgozoglu L, Monique Verschuren WM, Vlachopoulos C, Wood DA, Luis Zamorano J, Additional Contributor, Cooney MT (2017)
   2016 ESC/EAS Guidelines for the Management of Dyslipidaemias
   Rev Esp Cardiol (Engl Ed), 70 (2), 115
   DOI 10.1016/j.rec.2017.01.002, PubMed 29389351
8. Fonarow GC, Keech AC, Pedersen TR, Giugliano RP, Sever PS, Lindgren P, van Hout B, Villa G, Qian Y, Somaratne R, Sabatine MS (2017)
   Cost-effectiveness of Evolocumab Therapy for Reducing Cardiovascular Events in Patients With Atherosclerotic Cardiovascular Disease
   JAMA Cardiol, 2 (10), 1069-1078
   DOI 10.1001/jamacardio.2017.2762, PubMed 28832867
9. Giugliano RP, Keech A, Murphy SA, Huber K, Tokgozoglu SL, Lewis BS, Ferreira J, Pineda AL, Somaratne R, Sever PS, Pedersen TR, Sabatine MS (2017)
   Clinical Efficacy and Safety of Evolocumab in High-Risk Patients Receiving a Statin: Secondary Analysis of Patients With Low LDL Cholesterol Levels and in Those Already Receiving a Maximal-Potency Statin in a Randomized Clinical Trial
   JAMA Cardiol, 2 (12), 1385-1391
   DOI 10.1001/jamacardio.2017.3944, PubMed 29117276
10. Giugliano RP, Mach F, Zavitz K, Kurtz C, Im K, Kanevsky E, Schneider J, Wang H, Keech A, Pedersen TR, Sabatine MS, Sever PS, Robinson JG, Honarpour N, Wasserman SM, Ott BR, EBBINGHAUS Investigators (2017)
    Cognitive Function in a Randomized Trial of Evolocumab
    N Engl J Med, 377 (7), 633-643
    DOI 10.1056/NEJMoa1701131, PubMed 28813214
11. Giugliano RP, Mach F, Zavitz K, Kurtz C, Schneider J, Wang H, Keech A, Pedersen TR, Sabatine MS, Sever PS, Honarpour N, Wasserman SM, Ott BR, EBBINGHAUS Investigators (2017)
    Design and rationale of the EBBINGHAUS trial: A phase 3, double-blind, placebo-controlled, multicenter study to assess the effect of evolocumab on cognitive function in patients with clinically evident cardiovascular disease and receiving statin background lipid-lowering therapy-A cognitive study of patients enrolled in the FOURIER trial
    Clin Cardiol, 40 (2), 59-65
    DOI 10.1002/clc.22678, PubMed 28207168
12. Giugliano RP, Pedersen TR, Park JG, De Ferrari GM, Gaciong ZA, Ceska R, Toth K, Gouni-Berthold I, Lopez-Miranda J, Schiele F, Mach F, Ott BR, Kanevsky E, Pineda AL, Somaratne R, Wasserman SM, Keech AC, Sever PS, Sabatine MS, FOURIER Investigators (2017)
    Clinical efficacy and safety of achieving very low LDL-cholesterol concentrations with the PCSK9 inhibitor evolocumab: a prespecified secondary analysis of the FOURIER trial
    Lancet, 390 (10106), 1962-1971
    DOI 10.1016/S0140-6736(17)32290-0, PubMed 28859947
13. Greve AM, Bang CN, Boman K, Egstrup K, Forman JL, Kesäniemi YA, Ray S, Pedersen TR, Best P, Rajamannan NM, Wachtell K (2017)
    Effect Modifications of Lipid-Lowering Therapy on Progression of Aortic Stenosis (from the Simvastatin and Ezetimibe in Aortic Stenosis [SEAS] Study)
    Am J Cardiol, 121 (6), 739-745
    DOI 10.1016/j.amjcard.2017.12.011, PubMed 29361285
14. Klemsdal TO, Gjelsvik B, Elling I, Johansen S, Kjeldsen SE, Kristensen O, Madsen S, Njolstad I, Selmer R, Tonstad S, Voie H (2017)
    New guidelines for the prevention of cardiovascular disease
    Tidsskr. Nor. Laegeforen., 137 (16), 1164-1168
15. Mathisen TF, Rosenvinge JH, Pettersen G, Friborg O, Vrabel K, Bratland-Sanda S, Svendsen M, Stensrud T, Bakland M, Wynn R, Sundgot-Borgen J (2017)
    The PED-t trial protocol: The effect of physical exercise -and dietary therapy compared with cognitive behavior therapy in treatment of bulimia nervosa and binge eating disorder
    BMC Psychiatry, 17 (1), 180
    DOI 10.1186/s12888-017-1312-4, PubMed 28494809
16. Sabatine MS, Giugliano RP, Keech AC, Honarpour N, Wiviott SD, Murphy SA, Kuder JF, Wang H, Liu T, Wasserman SM, Sever PS, Pedersen TR, FOURIER Steering Committee and Investigators (2017)
    Evolocumab and Clinical Outcomes in Patients with Cardiovascular Disease
    N Engl J Med, 376 (18), 1713-1722
    DOI 10.1056/NEJMoa1615664, PubMed 28304224
17. Sabatine MS, Giugliano RP, Pedersen TR (2017)
    Evolocumab in Patients with Cardiovascular Disease
    N Engl J Med, 377 (8), 787-8
    DOI 10.1056/NEJMc1708587, PubMed 28834471
18. Sabatine MS, Leiter LA, Wiviott SD, Giugliano RP, Deedwania P, De Ferrari GM, Murphy SA, Kuder JF, Gouni-Berthold I, Lewis BS, Handelsman Y, Pineda AL, Honarpour N, Keech AC, Sever PS, Pedersen TR (2017)
    Cardiovascular safety and efficacy of the PCSK9 inhibitor evolocumab in patients with and without diabetes and the effect of evolocumab on glycaemia and risk of new-onset diabetes: a prespecified analysis of the FOURIER randomised controlled trial
    Lancet Diabetes Endocrinol, 5 (12), 941-950
    DOI 10.1016/S2213-8587(17)30313-3, PubMed 28927706
19. Thorolfsdottir RB, Sveinbjornsson G, Sulem P, Helgadottir A, Gretarsdottir S, Benonisdottir S, Magnusdottir A, Davidsson OB, Rajamani S, Roden DM, Darbar D, Pedersen TR, Sabatine MS, Jonsdottir I, Arnar DO, Thorsteinsdottir U, Gudbjartsson DF, Holm H, Stefansson K (2017)
    A Missense Variant in PLEC Increases Risk of Atrial Fibrillation
    J Am Coll Cardiol, 70 (17), 2157-2168
    DOI 10.1016/j.jacc.2017.09.005, PubMed 29050564
20. Tonstad S (2017)
    [Statin intolerance]
    Tidsskr Nor Laegeforen, 137 (1), 36-38
    DOI 10.4045/tidsskr.16.0646, PubMed 28073228
21. Vuorio A, Kuoppala J, Kovanen PT, Humphries SE, Tonstad S, Wiegman A, Drogari E, Ramaswami U (2017)
    Statins for children with familial hypercholesterolemia
    Cochrane Database Syst Rev, 7 (7), CD006401
    DOI 10.1002/14651858.CD006401.pub4, PubMed 28685504
22. Aambo A, Klemsdal TO (2017)
    Cardiovascular disease and diabetes by African or Asian background
    Tidsskr. Nor. Laegeforen., 137 (22), 1790-1794
23. Aambø A, Klemsdal TO (2017)
    Cardiovascular disease and diabetes in patients with African or Asian background
    Tidsskr Nor Laegeforen, 137 (22)
    DOI 10.4045/tidsskr.16.0680, PubMed 29181932

Publications 2016

1. Agca R, Heslinga SC, Rollefstad S, Heslinga M, McInnes IB, Peters MJ, Kvien TK, Dougados M, Radner H, Atzeni F, Primdahl J, Södergren A, Wallberg Jonsson S, van Rompay J, Zabalan C, Pedersen TR, Jacobsson L, de Vlam K, Gonzalez-Gay MA, Semb AG, Kitas GD, Smulders YM, Szekanecz Z, Sattar N, Symmons DP et al. (2016)
   EULAR recommendations for cardiovascular disease risk management in patients with rheumatoid arthritis and other forms of inflammatory joint disorders: 2015/2016 update
   Ann Rheum Dis, 76 (1), 17-28
   DOI 10.1136/annrheumdis-2016-209775, PubMed 27697765
2. Aune D, Keum N, Giovannucci E, Fadnes LT, Boffetta P, Greenwood DC, Tonstad S, Vatten LJ, Riboli E, Norat T (2016)
   Nut consumption and risk of cardiovascular disease, total cancer, all-cause and cause-specific mortality: a systematic review and dose-response meta-analysis of prospective studies
   BMC Med, 14 (1), 207
   DOI 10.1186/s12916-016-0730-3, PubMed 27916000
3. Aune D, Sen A, Norat T, Janszky I, Romundstad P, Tonstad S, Vatten LJ (2016)
   Body Mass Index, Abdominal Fatness, and Heart Failure Incidence and Mortality: A Systematic Review and Dose-Response Meta-Analysis of Prospective Studies
   Circulation, 133 (7), 639-49
   DOI 10.1161/CIRCULATIONAHA.115.016801, PubMed 26746176
4. Deedwania PC, Pedersen TR, DeMicco DA, Breazna A, Betteridge DJ, Hitman GA, Durrington P, Neil A, TNT, CARDS and IDEAL Steering Committees and Investigators (2016)
   Differing predictive relationships between baseline LDL-C, systolic blood pressure, and cardiovascular outcomes
   Int J Cardiol, 222, 548-556
   DOI 10.1016/j.ijcard.2016.07.201, PubMed 27513651
5. Ikdahl E, Rollefstad S, Hisdal J, Olsen IC, Pedersen TR, Kvien TK, Semb AG (2016)
   Sustained Improvement of Arterial Stiffness and Blood Pressure after Long-Term Rosuvastatin Treatment in Patients with Inflammatory Joint Diseases: Results from the RORA-AS Study
   PLoS One, 11 (4), e0153440
   DOI 10.1371/journal.pone.0153440, PubMed 27093159
6. Krosshaug T, Steffen K, Kristianslund E, Nilstad A, Mok KM, Myklebust G, Andersen TE, Holme I, Engebretsen L, Bahr R (2016)
   The Vertical Drop Jump Is a Poor Screening Test for ACL Injuries: Response
   Am J Sports Med, 44 (6), NP24-5
   DOI 10.1177/0363546516651042, PubMed 27252548
7. Krosshaug T, Steffen K, Kristianslund E, Nilstad A, Mok KM, Myklebust G, Andersen TE, Holme I, Engebretsen L, Bahr R (2016)
   Screening Tests for ACL Injury: Response
   Am J Sports Med, 44 (6), NP26-7
   DOI 10.1177/0363546516651046, PubMed 27252550
8. Larstorp AC, Tonstad S (2016)
   Effect of a Low Fat Diet Intervention on Blood Pressure and Hypertension: Rather Switch to a Mediterranean Diet?
   Am J Hypertens, 29 (8), 900-3
   DOI 10.1093/ajh/hpw054, PubMed 27245068
9. Masefield S, Powell P, Jiménez-Ruiz C, Hajek P, Lewis K, Andreas S, Tønnesen P, van Schayck O, Gratziou C, Dautzenberg B, Tonstad S, Hering T, Nardini S, Fletcher M (2016)
   Recommendations to improve smoking cessation outcomes from people with lung conditions who smoke
   ERJ Open Res, 2 (2)
   DOI 10.1183/23120541.00009-2016, PubMed 27730185
10. Nielsen OW, Sajadieh A, Sabbah M, Greve AM, Olsen MH, Boman K, Nienaber CA, Kesäniemi YA, Pedersen TR, Willenheimer R, Wachtell K (2016)
    Assessing Optimal Blood Pressure in Patients With Asymptomatic Aortic Valve Stenosis: The Simvastatin Ezetimibe in Aortic Stenosis Study (SEAS)
    Circulation, 134 (6), 455-68
    DOI 10.1161/CIRCULATIONAHA.115.021213, PubMed 27486164
11. Pedersen TR (2016)
    The Success Story of LDL Cholesterol Lowering
    Circ Res, 118 (4), 721-31
    DOI 10.1161/CIRCRESAHA.115.306297, PubMed 26892969
12. Tonstad S, Lawrence D (2016)
    Varenicline in smokers with diabetes: A pooled analysis of 15 randomized, placebo-controlled studies of varenicline
    J Diabetes Investig, 8 (1), 93-100
    DOI 10.1111/jdi.12543, PubMed 27223809

Publications 2015

1. Gerdts E, Rossebø AB, Pedersen TR, Cioffi G, Lønnebakken MT, Cramariuc D, Rogge BP, Devereux RB (2015)
   Relation of Left Ventricular Mass to Prognosis in Initially Asymptomatic Mild to Moderate Aortic Valve Stenosis
   Circ Cardiovasc Imaging, 8 (11), e003644; discussion e003644
   DOI 10.1161/CIRCIMAGING.115.003644, PubMed 26489804
2. Holme I, Tonstad S (2015)
   Survival in elderly men in relation to midlife and current BMI
   Age Ageing, 44 (3), 434-9
   DOI 10.1093/ageing/afu202, PubMed 25609234
3. Ikdahl E, Hisdal J, Rollefstad S, Olsen IC, Kvien TK, Pedersen TR, Semb AG (2015)
   Rosuvastatin improves endothelial function in patients with inflammatory joint diseases, longitudinal associations with atherosclerosis and arteriosclerosis: results from the RORA-AS statin intervention study
   Arthritis Res Ther, 17, 279
   DOI 10.1186/s13075-015-0795-y, PubMed 26445924
4. Jiménez-Ruiz CA, Andreas S, Lewis KE, Tonnesen P, van Schayck CP, Hajek P, Tonstad S, Dautzenberg B, Fletcher M, Masefield S, Powell P, Hering T, Nardini S, Tonia T, Gratziou C (2015)
   Statement on smoking cessation in COPD and other pulmonary diseases and in smokers with comorbidities who find it difficult to quit
   Eur Respir J, 46 (1), 61-79
   DOI 10.1183/09031936.00092614, PubMed 25882805
5. Pihlstrøm H, Dahle DO, Mjøen G, Pilz S, März W, Abedini S, Holme I, Fellström B, Jardine AG, Holdaas H (2015)
   Increased risk of all-cause mortality and renal graft loss in stable renal transplant recipients with hyperparathyroidism
   Transplantation, 99 (2), 351-9
   DOI 10.1097/TP.0000000000000583, PubMed 25594550
6. Preiss D, Campbell RT, Murray HM, Ford I, Packard CJ, Sattar N, Rahimi K, Colhoun HM, Waters DD, LaRosa JC, Amarenco P, Pedersen TR, Tikkanen MJ, Koren MJ, Poulter NR, Sever PS, Ridker PM, MacFadyen JG, Solomon SD, Davis BR, Simpson LM, Nakamura H, Mizuno K, Marfisi RM, Marchioli R et al. (2015)
   The effect of statin therapy on heart failure events: a collaborative meta-analysis of unpublished data from major randomized trials
   Eur Heart J, 36 (24), 1536-46
   DOI 10.1093/eurheartj/ehv072, PubMed 25802390
7. Rollefstad S, Ikdahl E, Hisdal J, Kvien TK, Pedersen TR, Semb AG (2015)
   Association of Chest Pain and Risk of Cardiovascular Disease with Coronary Atherosclerosis in Patients with Inflammatory Joint Diseases
   Front Med (Lausanne), 2, 80
   DOI 10.3389/fmed.2015.00080, PubMed 26618159
8. Rollefstad S, Ikdahl E, Hisdal J, Olsen IC, Holme I, Hammer HB, Smerud KT, Kitas GD, Pedersen TR, Kvien TK, Semb AG (2015)
   Rosuvastatin-Induced Carotid Plaque Regression in Patients With Inflammatory Joint Diseases: The Rosuvastatin in Rheumatoid Arthritis, Ankylosing Spondylitis and Other Inflammatory Joint Diseases Study
   Arthritis Rheumatol, 67 (7), 1718-28
   DOI 10.1002/art.39114, PubMed 25778850
9. Sabatine MS, Giugliano RP, Keech A, Honarpour N, Wang H, Liu T, Wasserman SM, Scott R, Sever PS, Pedersen TR (2015)
   Rationale and design of the Further cardiovascular OUtcomes Research with PCSK9 Inhibition in subjects with Elevated Risk trial
   Am Heart J, 173, 94-101
   DOI 10.1016/j.ahj.2015.11.015, PubMed 26920601
10. Stoekenbroek RM, Boekholdt SM, Fayyad R, Laskey R, Tikkanen MJ, Pedersen TR, Hovingh GK, Incremental Decrease in End Points Through Aggressive Lipid Lowering Study Group (2015)
    High-dose atorvastatin is superior to moderate-dose simvastatin in preventing peripheral arterial disease
    Heart, 101 (5), 356-62
    DOI 10.1136/heartjnl-2014-306906, PubMed 25595417
11. Strohmaier S, Røysland K, Hoff R, Borgan Ø, Pedersen TR, Aalen OO (2015)
    Dynamic path analysis - a useful tool to investigate mediation processes in clinical survival trials
    Stat Med, 34 (29), 3866-87
    DOI 10.1002/sim.6598, PubMed 26278111

Publications 2014

1. Aune D, Saugstad OD, Henriksen T, Tonstad S (2014)
   Physical activity and the risk of preeclampsia: a systematic review and meta-analysis
   Epidemiology, 25 (3), 331-43
   DOI 10.1097/EDE.0000000000000036, PubMed 24713878
2. Aune D, Saugstad OD, Henriksen T, Tonstad S (2014)
   Maternal body mass index and the risk of fetal death, stillbirth, and infant death: a systematic review and meta-analysis
   JAMA, 311 (15), 1536-46
   DOI 10.1001/jama.2014.2269, PubMed 24737366
3. Boekholdt SM, Hovingh GK, Mora S, Arsenault BJ, Amarenco P, Pedersen TR, LaRosa JC, Waters DD, DeMicco DA, Simes RJ, Keech AC, Colquhoun D, Hitman GA, Betteridge DJ, Clearfield MB, Downs JR, Colhoun HM, Gotto AM, Ridker PM, Grundy SM, Kastelein JJ (2014)
   Very low levels of atherogenic lipoproteins and the risk for cardiovascular events: a meta-analysis of statin trials
   J Am Coll Cardiol, 64 (5), 485-94
   DOI 10.1016/j.jacc.2014.02.615, PubMed 25082583
4. Dahle DO, Jenssen T, Holdaas H, Asberg A, Soveri I, Holme I, Mjøen G, Eide IA, Pihlstrøm H, Dörje C, Halden TA, Hartmann A (2014)
   Uric acid and clinical correlates of endothelial function in kidney transplant recipients
   Clin Transplant, 28 (10), 1167-76
   DOI 10.1111/ctr.12435, PubMed 25124959
5. Green A, Ramey DR, Emneus M, Iachina M, Stavem K, Bolin K, McNally R, Busch-Sørensen M, Willenheimer R, Egstrup K, Kesäniemi YA, Ray S, Basta N, Kent C, Pedersen TR (2014)
   Incidence of cancer and mortality in patients from the Simvastatin and Ezetimibe in Aortic Stenosis (SEAS) trial
   Am J Cardiol, 114 (10), 1518-22
   DOI 10.1016/j.amjcard.2014.08.016, PubMed 25267716
6. Holme I, Anderssen SA (2014)
   [Physical activity, smoking and mortality among men who participated in the Oslo studies of 1972 and 2000]
   Tidsskr Nor Laegeforen, 134 (18), 1743-8
   DOI 10.4045/tidsskr.14.0073, PubMed 25273247
7. Holme I, Tonstad S (2014)
   Increased predictive ability of BMI but not other risk factors with time in men: 39-year follow-up of total mortality in the Oslo Study
   Obes Facts, 7 (5), 311-21
   DOI 10.1159/000368567, PubMed 25300406
8. Jander N, Hochholzer W, Kaufmann BA, Bahlmann E, Gerdts E, Boman K, Chambers JB, Nienaber CA, Ray S, Rossebo A, Pedersen TR, Wachtell K, Gohlke-Bärwolf C, Neumann FJ, Minners J (2014)
   Velocity ratio predicts outcomes in patients with low gradient severe aortic stenosis and preserved EF
   Heart, 100 (24), 1946-53
   DOI 10.1136/heartjnl-2014-305763, PubMed 25217488
9. Jennings C, Kotseva K, De Bacquer D, Hoes A, de Velasco J, Brusaferro S, Mead A, Jones J, Tonstad S, Wood D, EUROACTION PLUS Study Group (2014)
   Effectiveness of a preventive cardiology programme for high CVD risk persistent smokers: the EUROACTION PLUS varenicline trial
   Eur Heart J, 35 (21), 1411-20
   DOI 10.1093/eurheartj/ehu051, PubMed 24616337
10. Minners J, Gohlke-Baerwolf C, Kaufmann BA, Bahlmann E, Gerdts E, Boman K, Chambers JB, Nienaber CA, Willenheimer R, Wachtell K, Holme I, Pedersen TR, Neumann FJ, Jander N (2014)
    Adjusting parameters of aortic valve stenosis severity by body size
    Heart, 100 (13), 1024-30
    DOI 10.1136/heartjnl-2013-305225, PubMed 24780909
11. Pihlstrøm H, Mjøen G, Dahle DO, Pilz S, Midtvedt K, März W, Abedini S, Holme I, Fellström B, Jardine A, Holdaas H (2014)
    Symmetric dimethylarginine as predictor of graft loss and all-cause mortality in renal transplant recipients
    Transplantation, 98 (11), 1219-25
    DOI 10.1097/TP.0000000000000205, PubMed 24999963
12. Rogge BP, Gerdts E, Cramariuc D, Bahlmann E, Jander N, Gohlke-Bärwolf C, Pedersen TR, Lønnebakken MT (2014)
    Impact of obesity and nonobesity on grading the severity of aortic valve stenosis
    Am J Cardiol, 113 (9), 1532-5
    DOI 10.1016/j.amjcard.2014.01.429, PubMed 24630788
13. Rollefstad S, Ikdahl E, Hisdal J, Kvien TK, Pedersen TR, Holme I, Semb AG (2014)
    Systemic inflammation in patients with inflammatory joint diseases does not influence statin dose needed to obtain LDL cholesterol goal in cardiovascular prevention
    Ann Rheum Dis, 74 (8), 1544-50
    DOI 10.1136/annrheumdis-2013-204636, PubMed 24699940
14. Sattar NA, Ginsberg H, Ray K, Chapman MJ, Arca M, Averna M, Betteridge DJ, Bhatnagar D, Bilianou E, Carmena R, Ceška R, Corsini A, Erbel R, Flynn PD, Garcia-Moll X, Gumprecht J, Ishibashi S, Jambart S, Kastelein JJ, Maher V, da Silva PM, Masana L, Odawara M, Pedersen TR, Rotella CM et al. (2014)
    The use of statins in people at risk of developing diabetes mellitus: evidence and guidance for clinical practice
    Atheroscler Suppl, 15 (1), 1-15
    DOI 10.1016/j.atherosclerosissup.2014.04.001, PubMed 24840509
15. Sletner L, Jenum AK, Mørkrid K, Vangen S, Holme IM, Birkeland KI, Nakstad B (2014)
    Maternal life course socio-economic position and offspring body composition at birth in a multi-ethnic population
    Paediatr Perinat Epidemiol, 28 (5), 445-54
    DOI 10.1111/ppe.12137, PubMed 25060595
16. STABILITY Investigators, White HD, Held C, Stewart R, Tarka E, Brown R, Davies RY, Budaj A, Harrington RA, Steg PG, Ardissino D, Armstrong PW, Avezum A, Aylward PE, Bryce A, Chen H, Chen MF, Corbalan R, Dalby AJ, Danchin N, De Winter RJ, Denchev S, Diaz R, Elisaf M, Flather MD et al. (2014)
    Darapladib for preventing ischemic events in stable coronary heart disease
    N Engl J Med, 370 (18), 1702-11
    DOI 10.1056/NEJMoa1315878, PubMed 24678955
17. Svendsen M, Tonstad S, Heggen E, Pedersen TR, Seljeflot I, Bøhn SK, Bastani NE, Blomhoff R, Holme IM, Klemsdal TO (2014)
    The effect of kiwifruit consumption on blood pressure in subjects with moderately elevated blood pressure: a randomized, controlled study
    Blood Press, 24 (1), 48-54
    DOI 10.3109/08037051.2014.976979, PubMed 25483553
18. Swerdlow DI, Preiss D, Kuchenbaecker KB, Holmes MV, Engmann JE, Shah T, Sofat R, Stender S, Johnson PC, Scott RA, Leusink M, Verweij N, Sharp SJ, Guo Y, Giambartolomei C, Chung C, Peasey A, Amuzu A, Li K, Palmen J, Howard P, Cooper JA, Drenos F, Li YR, Lowe G et al. (2014)
    HMG-coenzyme A reductase inhibition, type 2 diabetes, and bodyweight: evidence from genetic analysis and randomised trials
    Lancet, 385 (9965), 351-61
    DOI 10.1016/S0140-6736(14)61183-1, PubMed 25262344
19. Tonstad S, Gustavsson G, Kruse E, Walmsley JM, Westin Å (2014)
    Symptoms of nicotine toxicity in subjects achieving high cotinine levels during nicotine replacement therapy
    Nicotine Tob Res, 16 (9), 1266-71
    DOI 10.1093/ntr/ntu076, PubMed 24852574
20. Vuorio A, Kuoppala J, Kovanen PT, Humphries SE, Tonstad S, Wiegman A, Drogari E (2014)
    Statins for children with familial hypercholesterolemia
    Cochrane Database Syst Rev (7), CD006401
    DOI 10.1002/14651858.CD006401.pub3, PubMed 25054950

Publications 2013

1. Boekholdt SM, Arsenault BJ, Hovingh GK, Mora S, Pedersen TR, Larosa JC, Welch KM, Amarenco P, Demicco DA, Tonkin AM, Sullivan DR, Kirby A, Colhoun HM, Hitman GA, Betteridge DJ, Durrington PN, Clearfield MB, Downs JR, Gotto AM, Ridker PM, Kastelein JJ (2013)
   Levels and changes of HDL cholesterol and apolipoprotein A-I in relation to risk of cardiovascular events among statin-treated patients: a meta-analysis
   Circulation, 128 (14), 1504-12
   DOI 10.1161/CIRCULATIONAHA.113.002670, PubMed 23965489
2. Dorresteijn JA, Boekholdt SM, van der Graaf Y, Kastelein JJ, LaRosa JC, Pedersen TR, DeMicco DA, Ridker PM, Cook NR, Visseren FL (2013)
   High-dose statin therapy in patients with stable coronary artery disease: treating the right patients based on individualized prediction of treatment effect
   Circulation, 127 (25), 2485-93
   DOI 10.1161/CIRCULATIONAHA.112.000712, PubMed 23674398
3. Fagerström K, Tonstad S (2013)
   Reduced binding to nicotinic receptors after nicotine vaccination: is the effect big enough to be clinically meaningful?
   Am J Psychiatry, 170 (4), 359-61
   DOI 10.1176/appi.ajp.2012.12121604, PubMed 23545789
4. Gohlke-Bärwolf C, Minners J, Jander N, Gerdts E, Wachtell K, Ray S, Pedersen TR (2013)
   Natural history of mild and of moderate aortic stenosis-new insights from a large prospective European study
   Curr Probl Cardiol, 38 (9), 365-409
   DOI 10.1016/j.cpcardiol.2013.06.003, PubMed 23972937
5. Klemsdal TO (2013)
   [Tor Ole Klemsdal replies]
   Tidsskr Nor Laegeforen, 133 (6), 614
   DOI 10.4045/tidsskr.13.0277, PubMed 23552149
6. LaRosa JC, Pedersen TR, Somaratne R, Wasserman SM (2013)
   Safety and effect of very low levels of low-density lipoprotein cholesterol on cardiovascular events
   Am J Cardiol, 111 (8), 1221-9
   DOI 10.1016/j.amjcard.2012.12.052, PubMed 23375731
7. Mennen-Winchell LJ, Grigoriev V, Alpert P, Dos Santos H, Tonstad S (2013)
   Self-reported exercise and bone mineral density in prostate cancer patients receiving androgen deprivation therapy
   J Am Assoc Nurse Pract, 26 (1), 40-48
   DOI 10.1002/2327-6924.12066, PubMed 24170604
8. Mjøen G, Hallan S, Hartmann A, Foss A, Midtvedt K, Øyen O, Reisæter A, Pfeffer P, Jenssen T, Leivestad T, Line PD, Øvrehus M, Dale DO, Pihlstrøm H, Holme I, Dekker FW, Holdaas H (2013)
   Long-term risks for kidney donors
   Kidney Int, 86 (1), 162-7
   DOI 10.1038/ki.2013.460, PubMed 24284516
9. Pihlstrøm H, Mjøen G, März W, Olav Dahle D, Abedini S, Holme I, Fellström B, Jardine A, Pilz S, Holdaaas H (2013)
   Neopterin is associated with cardiovascular events and all-cause mortality in renal transplant patients
   Clin Transplant, 28 (1), 111-9
   DOI 10.1111/ctr.12285, PubMed 24372612
10. Schneider A, Jardine AG, Schneider MP, Holdaas H, Holme I, Fellstroem BC, Zannad F, Schmieder RE, AURORA Study Group (2013)
    Determinants of cardiovascular risk in haemodialysis patients: post hoc analyses of the AURORA study
    Am J Nephrol, 37 (2), 144-51
    DOI 10.1159/000346710, PubMed 23392089
11. Skretteberg PT, Grytten AN, Gjertsen K, Grundvold I, Kjeldsen SE, Erikssen J, Mellbin L, Liestøl K, Fraser DA, Erikssen G, Pedersen TR, Bodegard J (2013)
    Triglycerides-diabetes association in healthy middle-aged men: modified by physical fitness? A long term follow-up of 1962 Norwegian men in the Oslo Ischemia Study
    Diabetes Res Clin Pract, 101 (2), 201-9
    DOI 10.1016/j.diabres.2013.06.001, PubMed 23827210
12. Sletner L, Nakstad B, Yajnik CS, Mørkrid K, Vangen S, Vårdal MH, Holme IM, Birkeland KI, Jenum AK (2013)
    Ethnic differences in neonatal body composition in a multi-ethnic population and the impact of parental factors: a population-based cohort study
    PLoS One, 8 (8), e73058
    DOI 10.1371/journal.pone.0073058, PubMed 24009731
13. Soveri I, Snyder J, Holdaas H, Holme I, Jardine AG, L'Italien GJ, Fellström B (2013)
    The external validation of the cardiovascular risk equation for renal transplant recipients: applications to BENEFIT and BENEFIT-EXT trials
    Transplantation, 95 (1), 142-7
    DOI 10.1097/TP.0b013e31827722c9, PubMed 23192156
14. Tikkanen MJ, Fayyad R, Faergeman O, Olsson AG, Wun CC, Laskey R, Kastelein JJ, Holme I, Pedersen TR, IDEAL Investigators (2013)
    Effect of intensive lipid lowering with atorvastatin on cardiovascular outcomes in coronary heart disease patients with mild-to-moderate baseline elevations in alanine aminotransferase levels
    Int J Cardiol, 168 (4), 3846-52
    DOI 10.1016/j.ijcard.2013.06.024, PubMed 24001698
15. Tonstad S (2013)
    Weight gain does not attenuate cardiovascular benefits of smoking cessation
    Evid Based Med, 19 (1), 25
    DOI 10.1136/eb-2013-101350, PubMed 23723383
16. Tonstad S, Heggen E, Giljam H, Lagerbäck PÅ, Tønnesen P, Wikingsson LD, Lindblom N, de Villiers S, Svensson TH, Fagerström KO (2013)
    Niccine®, a nicotine vaccine, for relapse prevention: a phase II, randomized, placebo-controlled, multicenter clinical trial
    Nicotine Tob Res, 15 (9), 1492-501
    DOI 10.1093/ntr/ntt003, PubMed 23471101
17. Waters DD, Boekholdt SM, Pedersen TR (2013)
    Reply: To PMID 23219296
    J Am Coll Cardiol, 61 (18), 1934
    DOI 10.1016/j.jacc.2013.02.015, PubMed 23500266

Publications 2012

1. Boekholdt SM, Arsenault BJ, Mora S, Pedersen TR, LaRosa JC, Nestel PJ, Simes RJ, Durrington P, Hitman GA, Welch KM, DeMicco DA, Zwinderman AH, Clearfield MB, Downs JR, Tonkin AM, Colhoun HM, Gotto AM, Ridker PM, Kastelein JJ (2012)
   Association of LDL cholesterol, non-HDL cholesterol, and apolipoprotein B levels with risk of cardiovascular events among patients treated with statins: a meta-analysis
   JAMA, 307 (12), 1302-9
   DOI 10.1001/jama.2012.366, PubMed 22453571
2. Heggen E, Klemsdal TO, Haugen F, Holme I, Tonstad S (2012)
   Effect of a low-fat versus a low-gycemic-load diet on inflammatory biomarker and adipokine concentrations
   Metab Syndr Relat Disord, 10 (6), 437-42
   DOI 10.1089/met.2012.0012, PubMed 22889406
3. Holme I, Fellström BC, Jardine AG, Hartmann A, Holdaas H (2012)
   Model comparisons of competing risk and recurrent events for graft failure in renal transplant recipients
   Clin J Am Soc Nephrol, 8 (2), 241-7
   DOI 10.2215/CJN.03760412, PubMed 23160259
4. Karlsen A, Svendsen M, Seljeflot I, Laake P, Duttaroy AK, Drevon CA, Arnesen H, Tonstad S, Blomhoff R (2012)
   Kiwifruit decreases blood pressure and whole-blood platelet aggregation in male smokers
   J Hum Hypertens, 27 (2), 126-30
   DOI 10.1038/jhh.2011.116, PubMed 22258209
5. Kolsgaard ML, Joner G, Brunborg C, Anderssen SA, Tonstad S, Andersen LF (2012)
   Correction: "Reduction in BMI z-score and improvement in cardiometabolic risk factors in obese children and adolescents. The Oslo adiposity intervention study - a hospital/public health nurse combined treatment."
   BMC Pediatr, 12, 77
   DOI 10.1186/1471-2431-12-77, PubMed 22709339
6. Preiss D, Tikkanen MJ, Welsh P, Ford I, Lovato LC, Elam MB, LaRosa JC, DeMicco DA, Colhoun HM, Goldenberg I, Murphy MJ, MacDonald TM, Pedersen TR, Keech AC, Ridker PM, Kjekshus J, Sattar N, McMurray JJ (2012)
   Lipid-modifying therapies and risk of pancreatitis: a meta-analysis
   JAMA, 308 (8), 804-11
   DOI 10.1001/jama.2012.8439, PubMed 22910758
7. Rollefstad S, Kvien TK, Holme I, Eirheim AS, Pedersen TR, Semb AG (2012)
   Treatment to lipid targets in patients with inflammatory joint diseases in a preventive cardio-rheuma clinic
   Ann Rheum Dis, 72 (12), 1968-74
   DOI 10.1136/annrheumdis-2012-202789, PubMed 23264359
8. Schwartz GG, Olsson AG, Abt M, Ballantyne CM, Barter PJ, Brumm J, Chaitman BR, Holme IM, Kallend D, Leiter LA, Leitersdorf E, McMurray JJ, Mundl H, Nicholls SJ, Shah PK, Tardif JC, Wright RS, dal-OUTCOMES Investigators (2012)
   Effects of dalcetrapib in patients with a recent acute coronary syndrome
   N Engl J Med, 367 (22), 2089-99
   DOI 10.1056/NEJMoa1206797, PubMed 23126252
9. Semb AG, Kvien TK, DeMicco DA, Fayyad R, Wun CC, LaRosa J, Betteridge J, Pedersen TR, Holme I (2012)
   Prediction of cardiovascular events in patients with ankylosing spondylitis and psoriatic arthritis: role of lipoproteins in a high-risk population
   J Rheumatol, 39 (7), 1433-40
   DOI 10.3899/jrheum.111307, PubMed 22660802
10. Semb AG, Kvien TK, DeMicco DA, Fayyad R, Wun CC, LaRosa JC, Betteridge J, Pedersen TR, Holme I (2012)
    Effect of intensive lipid-lowering therapy on cardiovascular outcome in patients with and those without inflammatory joint disease
    Arthritis Rheum, 64 (9), 2836-46
    DOI 10.1002/art.34524, PubMed 22576673
11. Sletten IN, Nordsletten L, Hjorthaug GA, Hellund JC, Holme I, Kvernmo HD (2012)
    Assessment of volar angulation and shortening in 5th metacarpal neck fractures: an inter- and intra-observer validity and reliability study
    J Hand Surg Eur Vol, 38 (6), 658-66
    DOI 10.1177/1753193412461582, PubMed 23060463
12. Soveri I, Holme I, Holdaas H, Budde K, Jardine AG, Fellström B (2012)
    A cardiovascular risk calculator for renal transplant recipients
    Transplantation, 94 (1), 57-62
    DOI 10.1097/TP.0b013e3182516cdc, PubMed 22683851
13. Tonstad S, Aubin HJ (2012)
    Efficacy of a dose range of surinabant, a cannabinoid receptor blocker, for smoking cessation: a randomized controlled clinical trial
    J Psychopharmacol, 26 (7), 1003-9
    DOI 10.1177/0269881111431623, PubMed 22219220
14. Vollrath ME, Stene-Larsen K, Tonstad S, Rothbart MK, Hampson SE (2012)
    Associations between temperament at age 1.5 years and obesogenic diet at ages 3 and 7 years
    J Dev Behav Pediatr, 33 (9), 721-7
    DOI 10.1097/DBP.0b013e31826bac0d, PubMed 23117597
15. Waters DD, Ho JE, Boekholdt SM, DeMicco DA, Kastelein JJ, Messig M, Breazna A, Pedersen TR (2012)
    Cardiovascular event reduction versus new-onset diabetes during atorvastatin therapy: effect of baseline risk factors for diabetes
    J Am Coll Cardiol, 61 (2), 148-52
    DOI 10.1016/j.jacc.2012.09.042, PubMed 23219296

Publications 2011

1. Arsenault BJ, Boekholdt SM, Hovingh GK, Hyde CL, DeMicco DA, Chatterjee A, Barter P, Deedwania P, Waters DD, LaRosa JC, Pedersen TR, Kastelein JJ, TNT and IDEAL Investigators (2011)
   The 719Arg variant of KIF6 and cardiovascular outcomes in statin-treated, stable coronary patients of the treating to new targets and incremental decrease in end points through aggressive lipid-lowering prospective studies
   Circ Cardiovasc Genet, 5 (1), 51-7
   DOI 10.1161/CIRCGENETICS.111.960252, PubMed 22135385
2. Dahle DO, Mjøen G, Oqvist B, Scharnagl H, Weihrauch G, Grammer T, März W, Abedini S, Norby GE, Holme I, Fellström B, Jardine A, Holdaas H (2011)
   Inflammation-associated graft loss in renal transplant recipients
   Nephrol Dial Transplant, 26 (11), 3756-61
   DOI 10.1093/ndt/gfr163, PubMed 21511816
3. Fagerström KO, Gilljam H, Tonstad S (2011)
   [Good effect of varenicline in snuff use cessation. Double-blind placebo controlled comparative study]
   Lakartidningen, 108 (44), 2215-7
   PubMed 22165180
4. Greve AM, Gerdts E, Boman K, Gohlke-Baerwolf C, Rossebø AB, Nienaber CA, Ray S, Egstrup K, Pedersen TR, Køber L, Willenheimer R, Wachtell K (2011)
   Prognostic importance of atrial fibrillation in asymptomatic aortic stenosis: the Simvastatin and Ezetimibe in Aortic Stenosis study
   Int J Cardiol, 166 (1), 72-6
   DOI 10.1016/j.ijcard.2011.09.064, PubMed 21996417
5. Holdaas H, Holme I, Schmieder RE, Jardine AG, Zannad F, Norby GE, Fellström BC, AURORA study group (2011)
   Rosuvastatin in diabetic hemodialysis patients
   J Am Soc Nephrol, 22 (7), 1335-41
   DOI 10.1681/ASN.2010090987, PubMed 21566054
6. Holme I, Tonstad S (2011)
   [Risk factors and mortality--a follow-up of the Oslo Health Study from 1972-73]
   Tidsskr Nor Laegeforen, 131 (5), 456-60
   DOI 10.4045/tidsskr.10.0342, PubMed 21383797
7. Holme I, Aastveit AH, Hammar N, Jungner I, Walldius G (2011)
   High blood hemoglobin concentration as risk factor of major atherosclerotic cardiovascular events in 114,159 healthy men and women in the apolipoprotein mortality risk study (AMORIS)
   Ann Med, 44 (5), 476-86
   DOI 10.3109/07853890.2011.573804, PubMed 21585246
8. Holzmann MJ, Aastveit A, Hammar N, Jungner I, Walldius G, Holme I (2011)
   Renal dysfunction increases the risk of ischemic and hemorrhagic stroke in the general population
   Ann Med, 44 (6), 607-15
   DOI 10.3109/07853890.2011.582136, PubMed 21612332
9. Jander N, Minners J, Holme I, Gerdts E, Boman K, Brudi P, Chambers JB, Egstrup K, Kesäniemi YA, Malbecq W, Nienaber CA, Ray S, Rossebø A, Pedersen TR, Skjærpe T, Willenheimer R, Wachtell K, Neumann FJ, Gohlke-Bärwolf C (2011)
   Outcome of patients with low-gradient "severe" aortic stenosis and preserved ejection fraction
   Circulation, 123 (8), 887-95
   DOI 10.1161/CIRCULATIONAHA.110.983510, PubMed 21321152
10. Jander N, Minners J, Neumann FJ, Gohlke-Barwolf C, Holme I, Gerdts E, Boman K, Brudi P, Chambers JB, Egstrup K, Kesaniemi YA, Malbecq W, Nienaber CA, Ray S, Rossebo A, Pedersen TR, Skjaerpe T, Willenheimer R, Wachtell K (2011)
    Response to Letters Regarding Article, "Outcome of Patients With Low-Gradient "Severe" Aortic Stenosis and Preserved Ejection Fraction"
    Circulation, 124 (13), E362-E363
    DOI 10.1161/CIRCULATIONAHA.111.045203
11. Jenum AK, Mørkrid K, Sletner L, Vangen S, Torper JL, Nakstad B, Voldner N, Rognerud-Jensen OH, Berntsen S, Mosdøl A, Skrivarhaug T, Vårdal MH, Holme I, Yajnik CS, Birkeland KI (2011)
    Impact of ethnicity on gestational diabetes identified with the WHO and the modified International Association of Diabetes and Pregnancy Study Groups criteria: a population-based cohort study
    Eur J Endocrinol, 166 (2), 317-24
    DOI 10.1530/EJE-11-0866, PubMed 22108914
12. Karlsen A, Svendsen M, Seljeflot I, Sommernes MA, Sexton J, Brevik A, Erlund I, Serafini M, Bastani N, Remberg SF, Borge GI, Carlsen MH, Bøhn SK, Myhrstad MC, Dragsted LO, Duttaroy AK, Haffner K, Laake P, Drevon CA, Arnesen H, Collins A, Tonstad S, Blomhoff R (2011)
    Compliance, tolerability and safety of two antioxidant-rich diets: a randomised controlled trial in male smokers
    Br J Nutr, 106 (4), 557-71
    DOI 10.1017/S0007114511000353, PubMed 21806852
13. Kolsgaard ML, Joner G, Brunborg C, Anderssen SA, Tonstad S, Andersen LF (2011)
    Reduction in BMI z-score and improvement in cardiometabolic risk factors in obese children and adolescents. The Oslo Adiposity Intervention Study - a hospital/public health nurse combined treatment
    BMC Pediatr, 11, 47
    DOI 10.1186/1471-2431-11-47, PubMed 21619652
14. März W, Genser B, Drechsler C, Krane V, Grammer TB, Ritz E, Stojakovic T, Scharnagl H, Winkler K, Holme I, Holdaas H, Wanner C, German Diabetes and Dialysis Study Investigators (2011)
    Atorvastatin and low-density lipoprotein cholesterol in type 2 diabetes mellitus patients on hemodialysis
    Clin J Am Soc Nephrol, 6 (6), 1316-25
    DOI 10.2215/CJN.09121010, PubMed 21493741
15. Norheim OF, Gjelsvik B, Klemsdal TO, Madsen S, Meland E, Narvesen S, Negard A, Njolstad I, Tonstad S, Ulvin F, Wisloff T (2011)
    Norway's new principles for primary prevention of cardiovascular disease: age differentiated risk thresholds
    BMJ-British Medical Journal, 343, d3626
    DOI 10.1136/bmj.d3626
16. Olsson AG, Lindahl C, Holme I, Fayyad R, Faergeman O, Kastelein JJ, Tikkanen MJ, Larsen ML, Pedersen TR, Incremental Decrease in End Points Through Aggressive Lipid Lowering Study Group (2011)
    LDL cholesterol goals and cardiovascular risk during statin treatment: the IDEAL study
    Eur J Cardiovasc Prev Rehabil, 18 (2), 262-9
    DOI 10.1177/1741826710389391, PubMed 21450674
17. Preiss D, Seshasai SR, Welsh P, Murphy SA, Ho JE, Waters DD, DeMicco DA, Barter P, Cannon CP, Sabatine MS, Braunwald E, Kastelein JJ, de Lemos JA, Blazing MA, Pedersen TR, Tikkanen MJ, Sattar N, Ray KK (2011)
    Risk of incident diabetes with intensive-dose compared with moderate-dose statin therapy: a meta-analysis
    JAMA, 305 (24), 2556-64
    DOI 10.1001/jama.2011.860, PubMed 21693744
18. Skretteberg PT, Grundvold I, Kjeldsen SE, Erikssen JE, Sandvik L, Liestøl K, Erikssen G, Pedersen TR, Bodegard J (2011)
    HDL-cholesterol and prediction of coronary heart disease: modified by physical fitness? A 28-year follow-up of apparently healthy men
    Atherosclerosis, 220 (1), 250-6
    DOI 10.1016/j.atherosclerosis.2011.10.009, PubMed 22062589
19. Svendsen M, Tonstad S (2011)
    Orlistat after initial dietary/behavioural treatment: changes in body weight and dietary maintenance in subjects with sleep related breathing disorders
    Nutr J, 10, 21
    DOI 10.1186/1475-2891-10-21, PubMed 21385420

Publications 2010

1. Abedini S, Meinitzer A, Holme I, März W, Weihrauch G, Fellstrøm B, Jardine A, Holdaas H (2010)
   Asymmetrical dimethylarginine is associated with renal and cardiovascular outcomes and all-cause mortality in renal transplant recipients
   Kidney Int, 77 (1), 44-50
   DOI 10.1038/ki.2009.382, PubMed 19847152
2. Aronne LJ, Tonstad S, Moreno M, Gantz I, Erondu N, Suryawanshi S, Molony C, Sieberts S, Nayee J, Meehan AG, Shapiro D, Heymsfield SB, Kaufman KD, Amatruda JM (2010)
   A clinical trial assessing the safety and efficacy of taranabant, a CB1R inverse agonist, in obese and overweight patients: a high-dose study
   Int J Obes (Lond), 34 (5), 919-35
   DOI 10.1038/ijo.2010.21, PubMed 20157323
3. Bøhn SK, Myhrstad MC, Thoresen M, Holden M, Karlsen A, Tunheim SH, Erlund I, Svendsen M, Seljeflot I, Moskaug JO, Duttaroy AK, Laake P, Arnesen H, Tonstad S, Collins A, Drevon CA, Blomhoff R (2010)
   Blood cell gene expression associated with cellular stress defense is modulated by antioxidant-rich food in a randomised controlled clinical trial of male smokers
   BMC Med, 8, 54
   DOI 10.1186/1741-7015-8-54, PubMed 20846424
4. Einvik G, Klemsdal TO, Sandvik L, Hjerkinn EM (2010)
   A randomized clinical trial on n-3 polyunsaturated fatty acids supplementation and all-cause mortality in elderly men at high cardiovascular risk
   Eur J Cardiovasc Prev Rehabil, 17 (5), 588-92
   DOI 10.1097/HJR.0b013e328339cc70, PubMed 20389249
5. Fagerström K, Gilljam H, Metcalfe M, Tonstad S, Messig M (2010)
   Stopping smokeless tobacco with varenicline: randomised double blind placebo controlled trial
   BMJ, 341, c6549
   DOI 10.1136/bmj.c6549, PubMed 21134997
6. Gerdts E, Rossebø AB, Pedersen TR, Boman K, Brudi P, Chambers JB, Egstrup K, Gohlke-Bärwolf C, Holme I, Kesäniemi YA, Malbecq W, Nienaber C, Ray S, Skjærpe T, Wachtell K, Willenheimer R (2010)
   Impact of baseline severity of aortic valve stenosis on effect of intensive lipid lowering therapy (from the SEAS study)
   Am J Cardiol, 106 (11), 1634-9
   DOI 10.1016/j.amjcard.2010.07.042, PubMed 21094366
7. Holme I, Boman K, Brudi P, Egstrup K, Gohlke-Baerwolf C, Kesäniemi YA, Malbecq W, Rossebø AB, Wachtell K, Willenheimer R, Pedersen TR (2010)
   Observed and predicted reduction of ischemic cardiovascular events in the Simvastatin and Ezetimibe in Aortic Stenosis trial
   Am J Cardiol, 105 (12), 1802-8
   DOI 10.1016/j.amjcard.2010.01.363, PubMed 20538134
8. Holme I, Aastveit AH, Hammar N, Jungner I, Walldius G (2010)
   Inflammatory markers, lipoprotein components and risk of major cardiovascular events in 65,005 men and women in the Apolipoprotein MOrtality RISk study (AMORIS)
   Atherosclerosis, 213 (1), 299-305
   DOI 10.1016/j.atherosclerosis.2010.08.049, PubMed 20843515
9. Karlsen A, Paur I, Bøhn SK, Sakhi AK, Borge GI, Serafini M, Erlund I, Laake P, Tonstad S, Blomhoff R (2010)
   Bilberry juice modulates plasma concentration of NF-kappaB related inflammatory markers in subjects at increased risk of CVD
   Eur J Nutr, 49 (6), 345-55
   DOI 10.1007/s00394-010-0092-0, PubMed 20119859
10. Michelsen TM, Tonstad S, Pripp AH, Tropé CG, Dørum A (2010)
    Coronary heart disease risk profile in women who underwent salpingo-oophorectomy to prevent hereditary breast ovarian cancer
    Int J Gynecol Cancer, 20 (2), 233-9
    DOI 10.1111/igc.0b013e3181ca5ff4, PubMed 20169665
11. Mjoen G, Midtvedt K, Holme I, Øyen O, Fauchald P, Bergrem H, Holdaas H (2010)
    One- and five-year follow-ups on blood pressure and renal function in kidney donors
    Transpl Int, 24 (1), 73-7
    DOI 10.1111/j.1432-2277.2010.01148.x, PubMed 20723180
12. Pedersen TR, Cater NB, Faergeman O, Kastelein JJ, Olsson AG, Tikkanen MJ, Holme I, Larsen ML, Lindahl C, Szarek M (2010)
    Comparison of atorvastatin 80 mg/day versus simvastatin 20 to 40 mg/day on frequency of cardiovascular events late (five years) after acute myocardial infarction (from the Incremental Decrease in End Points through Aggressive Lipid Lowering [IDEAL] trial)
    Am J Cardiol, 106 (3), 354-9
    DOI 10.1016/j.amjcard.2010.03.033, PubMed 20643245
13. Rigotti NA, Pipe AL, Benowitz NL, Arteaga C, Garza D, Tonstad S (2010)
    Efficacy and safety of varenicline for smoking cessation in patients with cardiovascular disease: a randomized trial
    Circulation, 121 (2), 221-9
    DOI 10.1161/CIRCULATIONAHA.109.869008, PubMed 20048210
14. Rigotti NA, Pipe AL, Benowitz NL, Arteaga C, Garza D, Tonstad S (2010)
    Response to Letter Regarding Article, "Efficacy and Safety of Varenicline for Smoking Cessation in Patients With Cardiovascular Disease: A Randomized Trial"
    Circulation, 122 (9), E446
    DOI 10.1161/CIRCULATIONAHA.110.960856
15. Sattar N, Preiss D, Murray HM, Welsh P, Buckley BM, de Craen AJ, Seshasai SR, McMurray JJ, Freeman DJ, Jukema JW, Macfarlane PW, Packard CJ, Stott DJ, Westendorp RG, Shepherd J, Davis BR, Pressel SL, Marchioli R, Marfisi RM, Maggioni AP, Tavazzi L, Tognoni G, Kjekshus J, Pedersen TR, Cook TJ et al. (2010)
    Statins and risk of incident diabetes: a collaborative meta-analysis of randomised statin trials
    Lancet, 375 (9716), 735-42
    DOI 10.1016/S0140-6736(09)61965-6, PubMed 20167359
16. Semb AG, Holme I, Kvien TK, Pedersen TR (2010)
    Intensive lipid lowering in patients with rheumatoid arthritis and previous myocardial infarction: an explorative analysis from the incremental decrease in endpoints through aggressive lipid lowering (IDEAL) trial
    Rheumatology (Oxford), 50 (2), 324-9
    DOI 10.1093/rheumatology/keq295, PubMed 20884656
17. Semb AG, Kvien TK, Aastveit AH, Jungner I, Pedersen TR, Walldius G, Holme I (2010)
    Lipids, myocardial infarction and ischaemic stroke in patients with rheumatoid arthritis in the Apolipoprotein-related Mortality RISk (AMORIS) Study
    Ann Rheum Dis, 69 (11), 1996-2001
    DOI 10.1136/ard.2009.126128, PubMed 20551156
18. Solaas K, Legry V, Retterstol K, Berg PR, Holven KB, Ferrières J, Amouyel P, Lien S, Romeo J, Valtueña J, Widhalm K, Ruiz JR, Dallongeville J, Tonstad S, Rootwelt H, Halvorsen B, Nenseter MS, Birkeland KI, Thorsby PM, Meirhaeghe A, Nebb HI (2010)
    Suggestive evidence of associations between liver X receptor β polymorphisms with type 2 diabetes mellitus and obesity in three cohort studies: HUNT2 (Norway), MONICA (France) and HELENA (Europe)
    BMC Med Genet, 11, 144
    DOI 10.1186/1471-2350-11-144, PubMed 20939869
19. Tenga A, Holme I, Ronglan LT, Bahr R (2010)
    Effect of playing tactics on goal scoring in Norwegian professional soccer
    J Sports Sci, 28 (3), 237-44
    DOI 10.1080/02640410903502774, PubMed 20391095
20. Tenga A, Holme I, Ronglan LT, Bahr R (2010)
    Effect of playing tactics on achieving score-box possessions in a random series of team possessions from Norwegian professional soccer matches
    J Sports Sci, 28 (3), 245-55
    DOI 10.1080/02640410903502766, PubMed 20391096
21. Tonstad S, Davies S, Flammer M, Russ C, Hughes J (2010)
    Psychiatric adverse events in randomized, double-blind, placebo-controlled clinical trials of varenicline: a pooled analysis
    Drug Saf, 33 (4), 289-301
    DOI 10.2165/11319180-000000000-00000, PubMed 20297861
22. Tonstad S, Holme I, Tønnesen P (2010)
    Dianicline, a novel α4β2 nicotinic acetylcholine receptor partial agonist, for smoking cessation: a randomized placebo-controlled clinical trial
    Nicotine Tob Res, 13 (1), 1-6
    DOI 10.1093/ntr/ntq191, PubMed 21041839
23. van den Bogaard B, van den Born BJ, Fayyad R, Waters DD, DeMicco DA, LaRosa JC, Kastelein JJ, Holme I, Treating to New Targets investigators (2010)
    On-treatment lipoprotein components and risk of cerebrovascular events in the Treating to New Targets study
    Eur J Clin Invest, 41 (2), 134-42
    DOI 10.1111/j.1365-2362.2010.02387.x, PubMed 20868450
24. Vollrath ME, Tonstad S, Rothbart MK, Hampson SE (2010)
    Infant temperament is associated with potentially obesogenic diet at 18 months
    Int J Pediatr Obes, 6 (2-2), e408-14
    DOI 10.3109/17477166.2010.518240, PubMed 20854098
25. Vuorio A, Kuoppala J, Kovanen PT, Humphries SE, Strandberg T, Tonstad S, Gylling H (2010)
    Statins for children with familial hypercholesterolemia
    Cochrane Database Syst Rev (7), CD006401
    DOI 10.1002/14651858.CD006401.pub2, PubMed 20614444

Publications 2009

1. Abedini S, Holme I, Fellström B, Jardine A, Cole E, Maes B, Holdaas H, ALERT Study Group (2009)
   Cerebrovascular events in renal transplant recipients
   Transplantation, 87 (1), 112-7
   DOI 10.1097/TP.0b013e31818bfce8, PubMed 19136900
2. Abedini S, Holme I, März W, Weihrauch G, Fellström B, Jardine A, Cole E, Maes B, Neumayer HH, Grønhagen-Riska C, Ambühl P, Holdaas H, ALERT study group (2009)
   Inflammation in renal transplantation
   Clin J Am Soc Nephrol, 4 (7), 1246-54
   DOI 10.2215/CJN.00930209, PubMed 19541816
3. Einvik G, Ekeberg O, Klemsdal TO, Sandvik L, Hjerkinn EM (2009)
   Physical distress is associated with cardiovascular events in a high risk population of elderly men
   BMC Cardiovasc Disord, 9, 14
   DOI 10.1186/1471-2261-9-14, PubMed 19331677
4. Einvik G, Ekeberg O, Lavik JG, Ellingsen I, Klemsdal TO, Hjerkinn EM (2009)
   The influence of long-term awareness of hyperlipidemia and of 3 years of dietary counseling on depression, anxiety, and quality of life
   J Psychosom Res, 68 (6), 567-72
   DOI 10.1016/j.jpsychores.2009.11.004, PubMed 20488274
5. Faergeman O, Holme I, Fayyad R, Bhatia S, Grundy SM, Kastelein JJ, LaRosa JC, Larsen ML, Lindahl C, Olsson AG, Tikkanen MJ, Waters DD, Pedersen TR, Steering Committees of IDEAL and TNT Trials (2009)
   Plasma triglycerides and cardiovascular events in the Treating to New Targets and Incremental Decrease in End-Points through Aggressive Lipid Lowering trials of statins in patients with coronary artery disease
   Am J Cardiol, 104 (4), 459-63
   DOI 10.1016/j.amjcard.2009.04.008, PubMed 19660594
6. Halvorsen B, Heggen E, Ueland T, Smith C, Sandberg WJ, Damås JK, Otterdal K, Tonstad S, Aukrust P (2009)
   Treatment with the PPARgamma agonist rosiglitazone downregulates interleukin-1 receptor antagonist in individuals with metabolic syndrome
   Eur J Endocrinol, 162 (2), 267-73
   DOI 10.1530/EJE-09-0706, PubMed 19926782
7. Hampson SE, Tonstad S, Irgens LM, Meltzer HM, Vollrath ME (2009)
   Mothers' negative affectivity during pregnancy and food choices for their infants
   Int J Obes (Lond), 34 (2), 327-31
   DOI 10.1038/ijo.2009.230, PubMed 19918247
8. Heggen E, Granlund L, Pedersen JI, Holme I, Ceglarek U, Thiery J, Kirkhus B, Tonstad S (2009)
   Plant sterols from rapeseed and tall oils: effects on lipids, fat-soluble vitamins and plant sterol concentrations
   Nutr Metab Cardiovasc Dis, 20 (4), 258-65
   DOI 10.1016/j.numecd.2009.04.001, PubMed 19748247
9. Holme I, Fayyad R, Faergeman O, Kastelein JJ, Olsson AG, Tikkanen MJ, Larsen ML, Lindahl C, Holdaas H, Pedersen TR, Incremental Decrease in End Points Through Aggressive Lipid Lowering Study Group (2009)
   Cardiovascular outcomes and their relationships to lipoprotein components in patients with and without chronic kidney disease: results from the IDEAL trial
   J Intern Med, 267 (6), 567-75
   DOI 10.1111/j.1365-2796.2009.02176.x, PubMed 20141566
10. Holme I, Fellstrom B, Jardine A, Holdaas H (2009)
    Comparison of predictive ability of lipoprotein components to that of traditional risk factors of coronary events in renal transplant recipients
    Atherosclerosis, 208 (1), 234-9
    DOI 10.1016/j.atherosclerosis.2009.06.020, PubMed 19596331
11. Holme I, Strandberg TE, Faergeman O, Kastelein JJ, Olsson AG, Tikkanen MJ, Larsen ML, Lindahl C, Pedersen TR, Incremental Decrease in End Points Through Aggressive Lipid Lowering Study Group (2009)
    Congestive heart failure is associated with lipoprotein components in statin-treated patients with coronary heart disease Insights from the Incremental Decrease in End points Through Aggressive Lipid Lowering Trial (IDEAL)
    Atherosclerosis, 205 (2), 522-7
    DOI 10.1016/j.atherosclerosis.2009.01.023, PubMed 19327776
12. Holme I, Szarek M, Cater NB, Faergeman O, Kastelein JJ, Olsson AG, Tikkanen MJ, Larsen ML, Lindahl C, Pedersen TR, Incremental Decrease in End Points Through Aggressive Lipid Lowering Study Group (2009)
    Adherence-adjusted efficacy with intensive versus standard statin therapy in patients with acute myocardial infarction in the IDEAL study
    Eur J Cardiovasc Prev Rehabil, 16 (3), 315-20
    DOI 10.1097/HJR.0b013e32832130f5, PubMed 19322096
13. Holme I, Aastveit AH, Hammar N, Jungner I, Walldius G (2009)
    Uric acid and risk of myocardial infarction, stroke and congestive heart failure in 417,734 men and women in the Apolipoprotein MOrtality RISk study (AMORIS)
    J Intern Med, 266 (6), 558-70
    DOI 10.1111/j.1365-2796.2009.02133.x, PubMed 19563390
14. Holme I, Aastveit AH, Hammar N, Jungner I, Walldius G (2009)
    Haptoglobin and risk of myocardial infarction, stroke, and congestive heart failure in 342,125 men and women in the Apolipoprotein MOrtality RISk study (AMORIS)
    Ann Med, 41 (7), 522-32
    DOI 10.1080/07853890903089453, PubMed 19657769
15. Holme I, Aastveit AH, Hammar N, Jungner I, Walldius G (2009)
    Lipoprotein components and risk of congestive heart failure in 84,740 men and women in the Apolipoprotein MOrtality RISk study (AMORIS)
    Eur J Heart Fail, 11 (11), 1036-42
    DOI 10.1093/eurjhf/hfp129, PubMed 19801574
16. Khoury J, Amundsen AL, Tonstad S, Henriksen T, Ose L, Retterstøl K, Iversen PO (2009)
    Evidence for impaired physiological decrease in the uteroplacental vascular resistance in pregnant women with familial hypercholesterolemia
    Acta Obstet Gynecol Scand, 88 (2), 222-6
    DOI 10.1080/00016340802503047, PubMed 18972234
17. Klemsdal TO, Holme I, Nerland H, Pedersen TR, Tonstad S (2009)
    Effects of a low glycemic load diet versus a low-fat diet in subjects with and without the metabolic syndrome
    Nutr Metab Cardiovasc Dis, 20 (3), 195-201
    DOI 10.1016/j.numecd.2009.03.010, PubMed 19502017
18. Kolsgaard ML, Wangensteen T, Brunborg C, Joner G, Holven KB, Halvorsen B, Aukrust P, Tonstad S (2009)
    Elevated visfatin levels in overweight and obese children and adolescents with metabolic syndrome
    Scand J Clin Lab Invest, 69 (8), 858-64
    DOI 10.3109/00365510903348677, PubMed 19929281
19. Liavaag AH, Tonstad S, Pripp AH, Tropé C, Dørum A (2009)
    Prevalence and determinants of metabolic syndrome and elevated Framingham risk score in epithelial ovarian cancer survivors: a controlled observational study
    Int J Gynecol Cancer, 19 (4), 634-40
    DOI 10.1111/IGC.0b013e3181a13058, PubMed 19509562
20. Madsen S, Gjelsvik B, Kjeldsen SE, Klemsdal TO, Meland E, Narvesen S, Norheim OF, Njølstad I, Tonstad S, Ulvin F (2009)
    [Solid guidelines for prevention of cardiovascular diseases]
    Tidsskr Nor Laegeforen, 129 (16), 1660
    DOI 10.4045/tidsskr.09.0851, PubMed 19721488
21. Malterud K, Tonstad S (2009)
    Preventing obesity: challenges and pitfalls for health promotion
    Patient Educ Couns, 76 (2), 254-9
    DOI 10.1016/j.pec.2008.12.012, PubMed 19157764
22. Mielniczuk LM, Pfeffer MA, Lewis EF, Blazing MA, de Lemos JA, Mohanavelu S, Rouleau J, Fox K, Pedersen TR, Califf RM (2009)
    Acute decline in renal function, inflammation, and cardiovascular risk after an acute coronary syndrome
    Clin J Am Soc Nephrol, 4 (11), 1811-7
    DOI 10.2215/CJN.03510509, PubMed 19820133
23. Norby GE, Holme I, Fellström B, Jardine A, Cole E, Abedini S, Holdaas H, Assessment of Lescol in Renal Transplantation Study Group (2009)
    Effect of fluvastatin on cardiac outcomes in kidney transplant patients with systemic lupus erythematosus: a randomized placebo-controlled study
    Arthritis Rheum, 60 (4), 1060-4
    DOI 10.1002/art.24379, PubMed 19333947
24. Pedersen TR (2009)
    Lipid-lowering drugs and risk for cancer
    Curr Atheroscler Rep, 11 (5), 350-7
    DOI 10.1007/s11883-009-0053-3, PubMed 19664378
25. Rossebo AB, Pedersen TR, Kesaniemi YA (2009)
    Calcific Aortic Stenosis Reply
    N. Engl. J. Med., 360 (1), 85-86
26. Rossebø AB, Gerdts E, Pedersen TR, SEAS Study Steering Committee (2009)
    Aortic valve stenosis
    Lancet, 373 (9680), 2022-3; author reply 2023
    DOI 10.1016/S0140-6736(09)61104-1, PubMed 19524771
27. Schwartz GG, Olsson AG, Ballantyne CM, Barter PJ, Holme IM, Kallend D, Leiter LA, Leitersdorf E, McMurray JJ, Shah PK, Tardif JC, Chaitman BR, Duttlinger-Maddux R, Mathieson J, dal-OUTCOMES Committees and Investigators (2009)
    Rationale and design of the dal-OUTCOMES trial: efficacy and safety of dalcetrapib in patients with recent acute coronary syndrome
    Am Heart J, 158 (6), 896-901.e3
    DOI 10.1016/j.ahj.2009.09.017, PubMed 19958854
28. Strandberg TE, Holme I, Faergeman O, Kastelein JJ, Lindahl C, Larsen ML, Olsson AG, Pedersen TR, Tikkanen MJ, IDEAL Study Group (2009)
    Comparative effect of atorvastatin (80 mg) versus simvastatin (20 to 40 mg) in preventing hospitalizations for heart failure in patients with previous myocardial infarction
    Am J Cardiol, 103 (10), 1381-5
    DOI 10.1016/j.amjcard.2009.01.377, PubMed 19427432
29. Svendsen M, Helgeland M, Tonstad S (2009)
    The long-term influence of orlistat on dietary intake in obese subjects with components of metabolic syndrome
    J Hum Nutr Diet, 22 (1), 55-63
    DOI 10.1111/j.1365-277X.2008.00920.x, PubMed 19192027
30. Tikkanen MJ, Holme I, Cater NB, Szarek M, Faergeman O, Kastelein JJ, Olsson AG, Larsen ML, Lindahl C, Pedersen TR, Incremental DEcrease through Aggressive Lipid Lowering Investigators (2009)
    Comparison of efficacy and safety of atorvastatin (80 mg) to simvastatin (20 to 40 mg) in patients aged <65 versus >or=65 years with coronary heart disease (from the Incremental DEcrease through Aggressive Lipid Lowering [IDEAL] study)
    Am J Cardiol, 103 (5), 577-82
    DOI 10.1016/j.amjcard.2008.10.029, PubMed 19231315
31. Tikkanen MJ, Szarek M, Fayyad R, Holme I, Cater NB, Faergeman O, Kastelein JJ, Olsson AG, Larsen ML, Lindahl C, Pedersen TR, IDEAL Investigators (2009)
    Total cardiovascular disease burden: comparing intensive with moderate statin therapy insights from the IDEAL (Incremental Decrease in End Points Through Aggressive Lipid Lowering) trial
    J Am Coll Cardiol, 54 (25), 2353-7
    DOI 10.1016/j.jacc.2009.08.035, PubMed 20082922
32. Trøseid M, Seljeflot I, Weiss TW, Klemsdal TO, Hjerkinn EM, Arnesen H (2009)
    Arterial stiffness is independently associated with interleukin-18 and components of the metabolic syndrome
    Atherosclerosis, 209 (2), 337-9
    DOI 10.1016/j.atherosclerosis.2009.09.028, PubMed 19836750
33. Wangensteen T, Kolsgaard ML, Mattingsdal M, Joner G, Tonstad S, Undlien D, Retterstol L (2009)
    Mutations in the melanocortin 4 receptor (MC4R) gene in obese patients in Norway
    Exp Clin Endocrinol Diabetes, 117 (6), 266-73
    DOI 10.1055/s-0028-1102942, PubMed 19301229
34. Aasen G, Fagertun H, Tonstad S, Halse J (2009)
    Leg fat mass as measured by dual X-ray absorptiometry (DXA) impacts insulin resistance differently in obese women versus men
    Scand J Clin Lab Invest, 69 (2), 181-9
    DOI 10.1080/00365510802464641, PubMed 18937100

Publications 2008

1. Dørum A, Tonstad S, Liavaag AH, Michelsen TM, Hildrum B, Dahl AA (2008)
   Bilateral oophorectomy before 50 years of age is significantly associated with the metabolic syndrome and Framingham risk score: a controlled, population-based study (HUNT-2)
   Gynecol Oncol, 109 (3), 377-83
   DOI 10.1016/j.ygyno.2008.02.025, PubMed 18407340
2. Ellingsen I, Seljeflot I, Arnesen H, Tonstad S (2008)
   Vitamin C consumption is associated with less progression in carotid intima media thickness in elderly men: A 3-year intervention study
   Nutr Metab Cardiovasc Dis, 19 (1), 8-14
   DOI 10.1016/j.numecd.2008.01.006, PubMed 18472409
3. Halvorsen B, Otterdal K, Tonstad S, Aukrust P (2008)
   Smoking and Inflammation: Their Synergistic Roles in Chronic Disease
   Curr. Cardiovascu. Risk Rep., 2 (6), 446-451
   DOI 10.1007/s12170-008-0079-z
4. Halvorsen LK, Tonstad S (2008)
   [The metabolic syndrome among obese patients]
   Tidsskr Nor Laegeforen, 128 (20), 2305-7
   PubMed 19096484
5. Holme I, Cater NB, Faergeman O, Kastelein JJ, Olsson AG, Tikkanen MJ, Larsen ML, Lindahl C, Pedersen TR, Incremental Decrease in End-Points Through Aggressive Lipid-Lowering (IDEAL) Study Group (2008)
   Lipoprotein predictors of cardiovascular events in statin-treated patients with coronary heart disease. Insights from the Incremental Decrease In End-points Through Aggressive Lipid-lowering Trial (IDEAL)
   Ann Med, 40 (6), 456-64
   DOI 10.1080/07853890801964955, PubMed 19160529
6. Holme I, Aastveit AH, Jungner I, Walldius G (2008)
   Relationships between lipoprotein components and risk of myocardial infarction: age, gender and short versus longer follow-up periods in the Apolipoprotein MOrtality RISk study (AMORIS)
   J Intern Med, 264 (1), 30-8
   DOI 10.1111/j.1365-2796.2008.01925.x, PubMed 18298486
7. Hustvedt BE, Svendsen M, Løvø A, Ellegård L, Hallén J, Tonstad S (2008)
   Validation of ActiReg to measure physical activity and energy expenditure against doubly labelled water in obese persons
   Br J Nutr, 100 (1), 219-26
   DOI 10.1017/S0007114507886363, PubMed 18197993
8. Jenssen TG, Tonstad S, Claudi T, Midthjell K, Cooper J (2008)
   The gap between guidelines and practice in the treatment of type 2 diabetes A nationwide survey in Norway
   Diabetes Res Clin Pract, 80 (2), 314-20
   DOI 10.1016/j.diabres.2007.12.025, PubMed 18279994
9. Kastelein JJ, van der Steeg WA, Holme I, Gaffney M, Cater NB, Barter P, Deedwania P, Olsson AG, Boekholdt SM, Demicco DA, Szarek M, LaRosa JC, Pedersen TR, Grundy SM, TNT Study Group, IDEAL Study Group (2008)
   Lipids, apolipoproteins, and their ratios in relation to cardiovascular events with statin treatment
   Circulation, 117 (23), 3002-9
   DOI 10.1161/CIRCULATIONAHA.107.713438, PubMed 18519851
10. Kolsgaard ML, Andersen LF, Tonstad S, Brunborg C, Wangensteen T, Joner G (2008)
    Ethnic differences in metabolic syndrome among overweight and obese children and adolescents: the Oslo Adiposity Intervention Study
    Acta Paediatr, 97 (11), 1557-63
    DOI 10.1111/j.1651-2227.2008.00955.x, PubMed 18657125
11. Madsen EL, Rissanen A, Bruun JM, Skogstrand K, Tonstad S, Hougaard DM, Richelsen B (2008)
    Weight loss larger than 10% is needed for general improvement of levels of circulating adiponectin and markers of inflammation in obese subjects: a 3-year weight loss study
    Eur J Endocrinol, 158 (2), 179-87
    DOI 10.1530/EJE-07-0721, PubMed 18230824
12. Michelsen TM, Pripp AH, Tonstad S, Tropé CG, Dørum A (2008)
    Metabolic syndrome after risk-reducing salpingo-oophorectomy in women at high risk for hereditary breast ovarian cancer: a controlled observational study
    Eur J Cancer, 45 (1), 82-9
    DOI 10.1016/j.ejca.2008.09.028, PubMed 19008092
13. Pedersen TR (2008)
    Overview of clinical trials on calcific aortic stenosis
    Eur. Heart J. Suppl., 10 (E), E31-E40
    DOI 10.1093/eurheartj/sun014
14. Rossebø AB, Pedersen TR, Boman K, Brudi P, Chambers JB, Egstrup K, Gerdts E, Gohlke-Bärwolf C, Holme I, Kesäniemi YA, Malbecq W, Nienaber CA, Ray S, Skjaerpe T, Wachtell K, Willenheimer R, SEAS Investigators (2008)
    Intensive lipid lowering with simvastatin and ezetimibe in aortic stenosis
    N Engl J Med, 359 (13), 1343-56
    DOI 10.1056/NEJMoa0804602, PubMed 18765433
15. Steine K, Rossebø AB, Stugaard M, Pedersen TR (2008)
    Left ventricular systolic and diastolic function in asymptomatic patients with moderate aortic stenosis
    Am J Cardiol, 102 (7), 897-901
    DOI 10.1016/j.amjcard.2008.07.001, PubMed 18805118
16. Svendsen M, Rissanen A, Richelsen B, Rössner S, Hansson F, Tonstad S (2008)
    Effect of orlistat on eating behavior among participants in a 3-year weight maintenance trial
    Obesity (Silver Spring), 16 (2), 327-33
    DOI 10.1038/oby.2007.82, PubMed 18239640
17. Søgaard AJ, Meyer HE, Tonstad S, Håheim LL, Holme I (2008)
    Weight cycling and risk of forearm fractures: a 28-year follow-up of men in the Oslo Study
    Am J Epidemiol, 167 (8), 1005-13
    DOI 10.1093/aje/kwm384, PubMed 18303007
18. van der Steeg WA, Holme I, Boekholdt SM, Larsen ML, Lindahl C, Stroes ES, Tikkanen MJ, Wareham NJ, Faergeman O, Olsson AG, Pedersen TR, Khaw KT, Kastelein JJ (2008)
    High-density lipoprotein cholesterol, high-density lipoprotein particle size, and apolipoprotein A-I: significance for cardiovascular risk: the IDEAL and EPIC-Norfolk studies
    J Am Coll Cardiol, 51 (6), 634-42
    DOI 10.1016/j.jacc.2007.09.060, PubMed 18261682

Publications 2007

1. Catapano AL, Pedersen TR, de Backer G (2007)
   Averting a pandemic health crisis in Europe by 2020: what physicians need to know regarding cholesterol management
   Eur J Cardiovasc Prev Rehabil, 14 (2), 340-5
   DOI 10.1097/hjr.0b013e3280122868, PubMed 17446817
2. Chonchol M, Cook T, Kjekshus J, Pedersen TR, Lindenfeld J (2007)
   Simvastatin for secondary prevention of all-cause mortality and major coronary events in patients with mild chronic renal insufficiency
   Am J Kidney Dis, 49 (3), 373-82
   DOI 10.1053/j.ajkd.2006.11.043, PubMed 17336698
3. Dahl TB, Yndestad A, Skjelland M, Øie E, Dahl A, Michelsen A, Damås JK, Tunheim SH, Ueland T, Smith C, Bendz B, Tonstad S, Gullestad L, Frøland SS, Krohg-Sørensen K, Russell D, Aukrust P, Halvorsen B (2007)
   Increased expression of visfatin in macrophages of human unstable carotid and coronary atherosclerosis: possible role in inflammation and plaque destabilization
   Circulation, 115 (8), 972-80
   DOI 10.1161/CIRCULATIONAHA.106.665893, PubMed 17283255
4. Ellingsen I, Hjerkinn EM, Seljeflot I, Arnesen H, Tonstad S (2007)
   Consumption of fruit and berries is inversely associated with carotid atherosclerosis in elderly men
   Br J Nutr, 99 (3), 674-81
   DOI 10.1017/S0007114507832521, PubMed 17894919
5. Erondu N, Addy C, Lu K, Mallick M, Musser B, Gantz I, Proietto J, Astrup A, Toubro S, Rissannen AM, Tonstad S, Haynes WG, Gottesdiener KM, Kaufman KD, Amatruda JM, Heymsfield SB (2007)
   NPY5R antagonism does not augment the weight loss efficacy of orlistat or sibutramine
   Obesity (Silver Spring), 15 (8), 2027-42
   DOI 10.1038/oby.2007.242, PubMed 17712121
6. Fagerberg B, Schuster H, Birketvedt GS, Tonstad S, Ohman KP, Gause-Nilsson I, SIR Study Group (2007)
   Improvement of postprandial lipid handling and glucose tolerance in a non-diabetic population by the dual PPARalpha/gamma agonist, tesaglitazar
   Diab Vasc Dis Res, 4 (3), 174-80
   DOI 10.3132/dvdr.2007.038, PubMed 17907107
7. Graff-Iversen S, Anderssen SA, Holme IM, Jenum AK, Raastad T (2007)
   An adapted version of the long International Physical Activity Questionnaire (IPAQ-L): construct validity in a low-income, multiethnic population study from Oslo, Norway
   Int J Behav Nutr Phys Act, 4, 13
   DOI 10.1186/1479-5868-4-13, PubMed 17448225
8. Halvorsen B, Lund Sagen E, Ueland T, Aukrust P, Tonstad S (2007)
   Effect of smoking cessation on markers of inflammation and endothelial cell activation among individuals with high risk for cardiovascular disease
   Scand J Clin Lab Invest, 67 (6), 604-11
   DOI 10.1080/00365510701283878, PubMed 17852807
9. Hjelstuen A, Anderssen SA, Holme I, Seljeflot I, Klemsdal TO (2007)
   Effect of lifestyle and/or statin treatment on soluble markers of atherosclerosis in hypertensives
   Scand Cardiovasc J, 41 (5), 313-20
   DOI 10.1080/14017430701411234, PubMed 17852781
10. Holme I, Sogaard AJ, Haheim LL, Larsen PG, Tonstad S (2007)
    Repeated Weight Loss is Associated with the Metabolic Syndrome and Diabetes: Results of a 28 Year Re-screening of Men in the Oslo Study
    Metab Syndr Relat Disord, 5 (2), 127-35
    DOI 10.1089/met.2007.0003, PubMed 18370821
11. Holme I, Tonstad S, Sogaard AJ, Larsen PG, Haheim LL (2007)
    Leisure time physical activity in middle age predicts the metabolic syndrome in old age: results of a 28-year follow-up of men in the Oslo study
    BMC Public Health, 7, 154
    DOI 10.1186/1471-2458-7-154, PubMed 17625024
12. Håheim LL, Tonstad S, Hjermann I, Leren P, Holme I (2007)
    Predictiveness of body mass index for fatal coronary heart disease in men according to length of follow-up: a 21-year prospective cohort study
    Scand J Public Health, 35 (1), 4-10
    DOI 10.1080/14034940510032293, PubMed 17366081
13. Khoury J, Haugen G, Tonstad S, Frøslie KF, Henriksen T (2007)
    Effect of a cholesterol-lowering diet during pregnancy on maternal and fetal Doppler velocimetry: the CARRDIP study
    Am J Obstet Gynecol, 196 (6), 549.e1-7
    DOI 10.1016/j.ajog.2007.01.017, PubMed 17547890
14. Khoury J, Henriksen T, Seljeflot I, Mørkrid L, Frøslie KF, Tonstad S (2007)
    Effects of an antiatherogenic diet during pregnancy on markers of maternal and fetal endothelial activation and inflammation: the CARRDIP study
    BJOG, 114 (3), 279-88
    DOI 10.1111/j.1471-0528.2006.01187.x, PubMed 17217362
15. Lorentzen C, Ommundsen Y, Holme I (2007)
    Psychosocial correlates of stages of change in physical activity in an adult community sample
    Eur. J. Sport Sci., 7 (2), 93-106
    DOI 10.1080/17461390701456122
16. Pedersen TR (2007)
    Viewpoint: Terje R. Pedersen, MD, PhD. Interview by Robert Short
    Circulation, 115 (12), f51-2
    PubMed 17393574
17. Pedersen TR (2007)
    Statin therapy: changing the mode of coronary heart disease
    Cardiology, 109 (3), 154-5
    DOI 10.1159/000106675, PubMed 17728542
18. Richelsen B, Tonstad S, Rössner S, Toubro S, Niskanen L, Madsbad S, Mustajoki P, Rissanen A (2007)
    Effect of orlistat on weight regain and cardiovascular risk factors following a very-low-energy diet in abdominally obese patients: a 3-year randomized, placebo-controlled study
    Diabetes Care, 30 (1), 27-32
    DOI 10.2337/dc06-0210, PubMed 17192328
19. Rossebø AB, Pedersen TR, Allen C, Boman K, Chambers J, Egstrup K, Gerdts E, Gohlke-Bärwolf C, Holme I, Kesäniemi VA, Malbecq W, Nienaber C, Ray S, Skjaerpe T, Wachtell K, Willenheimer R (2007)
    Design and baseline characteristics of the simvastatin and ezetimibe in aortic stenosis (SEAS) study
    Am J Cardiol, 99 (7), 970-3
    DOI 10.1016/j.amjcard.2006.10.064, PubMed 17398194
20. Schuster H, Fagerberg B, Edwards S, Halmos T, Lopatynski J, Stender S, Birketvedt GS, Tonstad S, Gause-Nilsson I, Halldórsdóttir S, Ohman KP, SIR Investigators (2007)
    Tesaglitazar, a dual peroxisome proliferator-activated receptor alpha/gamma agonist, improves apolipoprotein levels in non-diabetic subjects with insulin resistance
    Atherosclerosis, 197 (1), 355-62
    DOI 10.1016/j.atherosclerosis.2007.05.029, PubMed 17631296
21. Sniderman AD, Holme I, Aastveit A, Furberg C, Walldius G, Jungner I (2007)
    Relation of age, the apolipoprotein B/apolipoprotein A-I ratio, and the risk of fatal myocardial infarction and implications for the primary prevention of cardiovascular disease
    Am J Cardiol, 100 (2), 217-21
    DOI 10.1016/j.amjcard.2007.02.086, PubMed 17631073
22. Stein EA, Ose L, Retterstøl K, Tonstad S, Schleman M, Harris S, Sager P (2007)
    Further reduction of low-density lipoprotein cholesterol and C-reactive protein with the addition of ezetimibe to maximum-dose rosuvastatin in patients with severe hypercholesterolemia
    J Clin Lipidol, 1 (4), 280-6
    DOI 10.1016/j.jacl.2007.07.003, PubMed 21291692
23. Svendsen M, Blomhoff R, Holme I, Tonstad S (2007)
    The effect of an increased intake of vegetables and fruit on weight loss, blood pressure and antioxidant defense in subjects with sleep related breathing disorders
    Eur J Clin Nutr, 61 (11), 1301-11
    DOI 10.1038/sj.ejcn.1602652, PubMed 17268408
24. Søgaard AJ, Dalgard OS, Holme I, Røysamb E, Håheim LL (2007)
    Associations between type A behaviour pattern and psychological distress : 28 years of follow-up of the Oslo Study 1972/1973
    Soc Psychiatry Psychiatr Epidemiol, 43 (3), 216-23
    DOI 10.1007/s00127-007-0288-7, PubMed 18084687
25. Walldius G, Holme I, Jungner I (2007)
    [Apolipoproteins are better risk markers than conventional lipids]
    Lakartidningen, 104 (37), 2612-3
    PubMed 17970399

Publications 2006

1. Amundsen AL, Khoury J, Iversen PO, Bergei C, Ose L, Tonstad S, Retterstøl K (2006)
   Marked changes in plasma lipids and lipoproteins during pregnancy in women with familial hypercholesterolemia
   Atherosclerosis, 189 (2), 451-7
   DOI 10.1016/j.atherosclerosis.2006.01.002, PubMed 16466729
2. Amundsen AL, Khoury J, Sandset PM, Seljeflot I, Ose L, Tonstad S, Henriksen T, Retterstøl K, Iversen PO (2006)
   Altered hemostatic balance and endothelial activation in pregnant women with familial hypercholesterolemia
   Thromb Res, 120 (1), 21-7
   DOI 10.1016/j.thromres.2006.07.001, PubMed 16914186
3. Bergstrøm H, Tonstad S (2006)
   Combined hormone replacement therapy improves lipids but may increase leucocytes
   J Intern Med, 259 (5), 537-8
   DOI 10.1111/j.1365-2796.2006.01636.x, PubMed 16629858
4. Ellingsen I, Hjerkinn EM, Arnesen H, Seljeflot I, Hjermann I, Tonstad S (2006)
   Follow-up of diet and cardiovascular risk factors 20 years after cessation of intervention in the Oslo Diet and Antismoking Study
   Eur J Clin Nutr, 60 (3), 378-85
   DOI 10.1038/sj.ejcn.1602327, PubMed 16306931
5. Graff-Iversen S, Hammar N, Thelle DS, Tonstad S (2006)
   Use of oral contraceptives and mortality during 14 years' follow-up of Norwegian women
   Scand J Public Health, 34 (1), 11-6
   DOI 10.1080/14034940510032239, PubMed 16449039
6. Hjelstuen A, Anderssen SA, Holme I, Seljeflot I, Klemsdal TO (2006)
   Markers of inflammation are inversely related to physical activity and fitness in sedentary men with treated hypertension
   Am J Hypertens, 19 (7), 669-75; discussion 676-7
   DOI 10.1016/j.amjhyper.2005.11.012, PubMed 16814119
7. Holme I, Søgaard AJ, Lund-Larsen PG, Tonstad S, Håheim LL (2006)
   [Is a healthy lifestyle worthwhile?]
   Tidsskr Nor Laegeforen, 126 (17), 2246-9
   PubMed 16967061
8. Håheim LL, Holme I, Søgaard AJ, Lund-Larsen PG (2006)
   [Changes in cardiovascular risk factors among men in Oslo during 28 years]
   Tidsskr Nor Laegeforen, 126 (17), 2240-5
   PubMed 16967060
9. Ilkova H, Pedersen TR, Shepherd J (2006)
   Proceedings of the 2nd International Merck Symposium on HDL-C Raising - Bridging the gap in cardiovascular risk reduction: A call to action - Barcelona, 14-15 October, 2005 - Guest editorial
   Eur. Heart J. Suppl., 8 (F), F3
   DOI 10.1093/eurheartj/sul033
10. Jorenby DE, Tonstad S, Gonzales D (2006)
    Efficacy of varenicline for smoking cessation - Reply
    JAMA-J. Am. Med. Assoc., 296 (21), 2555-2556
    DOI 10.1001/jama.296.21.2555-b
11. Jungner I, Sniderman AD, Furberg C, Aastveit AH, Holme I, Walldius G (2006)
    Does low-density lipoprotein size add to atherogenic particle number in predicting the risk of fatal myocardial infarction?
    Am J Cardiol, 97 (7), 943-6
    DOI 10.1016/j.amjcard.2005.10.062, PubMed 16563891
12. Lund Håheim L, Holme I, Hjermann I, Tonstad S (2006)
    Risk-factor profile for the incidence of subarachnoid and intracerebral haemorrhage, cerebral infarction, and unspecified stroke during 21 years' follow-up in men
    Scand J Public Health, 34 (6), 589-97
    DOI 10.1080/14034940600731523, PubMed 17132592
13. Pedersen TR (2006)
    The gap between theory and practice: what do the trials tell us?
    Eur. Heart J. Suppl., 8 (F), F10-F16
    DOI 10.1093/eurheartj/sul035
14. Svendsen M, Tonstad S (2006)
    Accuracy of food intake reporting in obese subjects with metabolic risk factors
    Br J Nutr, 95 (3), 640-9
    DOI 10.1079/bjn20051662, PubMed 16512951
15. Tonstad S, Andrew Johnston J (2006)
    Cardiovascular risks associated with smoking: a review for clinicians
    Eur J Cardiovasc Prev Rehabil, 13 (4), 507-14
    DOI 10.1097/01.hjr.0000214609.06738.62, PubMed 16874138
16. Tonstad S, Klemsdal TO, Landaas S, Høieggen A (2006)
    No effect of increased water intake on blood viscosity and cardiovascular risk factors
    Br J Nutr, 96 (6), 993-6
    DOI 10.1017/bjn20061969, PubMed 17181872
17. Trøseid M, Hjerkinn EM, Seljeflot I, Klemsdal TO, Bergengen L, Breivik L, Arnesen H (2006)
    Comparison of biochemical, functional and structural aspects of arterial wall properties in elderly men
    Scand J Clin Lab Invest, 66 (2), 137-45
    DOI 10.1080/00365510500474462, PubMed 16537247